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ABSTRACT OF THE DISSERTATION
Adaptive Mechanisms to Niche Remodeling in Streptococcus pyogenes
By
Elyse Paluscio
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Microbiology and Microbial Pathogenesis
Washington University in St. Louis, 2015
Professor Michael Caparon, Chairperson

The Gram-positive bacterium Streptococcus pyogenes is a remarkably successful
pathogen, capable of infecting numerous tissue sites within its human host. The ability of S.
pyogenes to invade these different niches is, in part, due to the species’ ability to monitor various
physical and chemical signals in its environment and alter its transcriptional profile in response
to these differential conditions. As a member of the lactic acid bacteria, S. pyogenes has a simple
fermentative metabolism and relies exclusively on a combination of homo-lactic and mixed acid
fermentation as a means of generating energy in the cell. As a consequence of its fermentative
metabolism, S. pyogenes produces several organic acid end products that, over time, accumulate
in the surrounding environment, causing a substantial reduction in pH. Thus, growth of the
bacterium itself results in a significant remodeling of its local tissue environment. It also
indicates that over the course of infection, it must both adapt to its self-inflicted acid stress as
well as exploit alternative carbon sources for survival. Although pH has been identified as a
signal utilized by S. pyogenes to induce global transcriptional changes, the specific regulatory
mechanisms behind this transcriptional remodeling have largely remained unclear. To further
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characterize the process of S. pyogenes’ pH adaptive response we have identified several novel
pH-sensitive transcriptional regulators and analyzed their contribution to gene expression and S.
pyogenes pathogenesis.
The malic enzyme pathway, which allows the cell to utilize malate as a carbon source for
growth, consists of four genes in two adjacent operons, with the regulatory TCS MaeKR being
required for the expression of the genes encoding a malate permease (maeP) and malic enzyme
(maeE). Results show that expression of the maePE operon is influenced independently by
external malate concentrations and pH in a MaeK-dependent mechanism. The ME genes are
additionally regulated by a unique CcpA-independent form of catabolite repression which
involves the PTS proteins PtsI and HPr. Furthermore, in vivo experiments demonstrate that loss
of any individual ME gene has a significant effect on the outcome of a soft tissue infection.
The secreted toxins SPN and SLO have been shown to contribute to S. pyogenes
cytotoxicity and virulence in multiple models of pathogenesis, however little information is
known about the specific regulatory mechanism that control expression of these toxins. Our work
has determined that the growth-phase pattern of expression of the spn/slo operon is regulated by
environmental pH. Additionally, this regulation requires both the CovRS two-component system
as well as an additional protein, RocA. Additional data suggests that RocA does not function as a
traditional histidine kinase, despite high structural and sequence homology to known histidine
kinases such as CovS. However, all three regulatory proteins are required for the pH-mediated
regulation of this virulence operon.
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Overview of Streptococcus pyogenes and streptococcal diseases
Streptococcus pyogenes (GAS) is a Gram-positive, chain forming bacterium that is able
to invade numerous different tissue sites within the host. S. pyogenes, a strict human pathogen, is
responsible for numerous superficial and systemic diseases and is believed to cause a wider
range of human diseases than any other bacterial pathogen (3-7).
S. pyogenes primarily causes superficial, self-limiting infections of the skin (impetigo)
and throat (pharyngitis) (3, 7, 8). These diseases are typically limited to the initial site of
infection and do not invade deeper tissues. S. pyogenes is the most common causative agent of
pharyngitis, with approximately 600 million cases annually (11). The symptoms of pharyngitis
include a sore throat and sudden onset fever. The sore throat is due to inflammation of the tonsils
and pharynx, often with patchy exudates and enlarged lymph nodes (11). Pharyngitis is typically
spread directly from person-to-person contact through nasal secretion or saliva droplets from
infected individuals. Incidence of pharyngitis is highest in crowded places, such as schools,
where approximately 15% of school children will contract the disease in developed countries
(12). Impetigo is caused by a S. pyogenes infection of the skin, leading to the formation of large
pustules that, once ruptured, will form thick, honey-colored scabs (11). This disease is spread by
direct skin contact and is most often seen in children living in tropical or subtropical climates and
in areas with poor hygiene (11). Despite the increasing numbers of antibiotic resistant pathogens,
S. pyogenes remains sensitive to penicillin, and this is generally the first line of treatment for
these superficial infections (13).
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Figure 1. Pathogenesis of S. pyogenes. Diagram of host tissue sites and the resulting diseases caused.
Adapted from (9).

Less frequent than the superficial infections of the skin and throat, S. pyogenes can also
breach the epithelial barriers to cause a number of invasive diseases. These types of infections
have a high morbidity and mortality rate, where approximately 8-23% of invasive infections lead
to death within 7 days (14-16). The most common systemic diseases caused by S. pyogenes are
cellulitis and bacteremia (11). Although less common, S. pyogenes can also cause necrotizing
fasciitis and streptococcal toxic shock syndrome (STSS) (17). In the case of necrotizing fasciitis,
antibiotic treatment with penicillin has little effect on the spread of the disease, suggesting that
the release of bacterial toxins, not growth of the bacteria itself, is the main contributor of this
disease (18). The main treatment for necrotizing fasciitis is surgical debridement of infected
tissue, however mortality rates for this type disseminating disease is quite low (less than 20%)
(11, 14-16).
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Additionally, prior S. pyogenes infections can lead to a number of postinfectious
sequelae, which include diseases such as acute rheumatic fever (ARF) and acute
poststreptococcal glomerulonephritis (APSGN) (7, 11, 12). ARF, which can occur as a result of
an untreated pharyngeal infection, can cause inflammation of the joints, heart, or neurological
symptoms (17, 19). ARF is a major source of morbidity and mortality worldwide, causing longterm damage to the heart (rheumatic heard disease or RHD). As a result, RHD is the most
common cause of pediatric heart disease worldwide, with over 2.4 million cases in children ages
5 to 14 (11, 19). APSGN results from an immune complex-mediated disorder that affects the
kidneys. Symptoms of this disease include edema, hypertension, and urinary sediment
abnormalities (11). Globally, there are over 470,000 cases diagnosed annually, with the highest
rates seen in children in undeveloped countries (11). However, unlike ARF, with proper medical
care, long-term damage from APSGN is rare (11).

Streptococcus pyogenes Pathogenesis
S. pyogenes’ ability to successfully invade numerous tissue sites within its human host is,
in part, due to its ability to produce a wide array of virulence factors throughout the infection
cycle. These virulence factors, which include surface attached and secreted proteins, enable the
bacterium to both inflict tissue damage to the host cells as well as evade the onslaught of
immune factors produced by the host. The following sections will explore the function of several
of the major virulence factors in S. pyogenes and their role in pathogenesis.
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Figure 2. Virulence factors produced by S. pyogenes. The bacterium produces over 40 virulence
secreted and surface exposed factors that contribute to adherence, tissue damage, and immune
evasion. Adapted from (7).

Surface-associated virulence factors
Lipoteichoic acid (LTA)
The first step required for S. pyogenes to successfully invade host tissue is to adhere to
human cells. Adherence is thought to be a two-step process, beginning with LTA. Bound to the
surface of the bacterial cell, LTA is an amphiphilic polymer of glycerol phosphate containing
glucose and D-alanine substitutes (10, 11, 20). It’s thought that these polymers are involved in
weak hydrophobic interactions with various host cell components. This initial interaction
between the bacterial and host cell can then allow long-distance attachments and higher-affinity
binding events (21).
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M protein
The surface-attached M protein is one of the most well characterized virulence factors
produced by S pyogenes. It is a fibrillar protein made up of α-helical coiled-coil dimers and is
attached to the cell wall through the function of sortase and an LPXTG motif (21-24). S.
pyogenes strains are classified by emm types, which are identified by the hypervariable region of
the N-terminal sequence of the protein (21). Following the hypervariable region is a set of four
repeat regions (A-D), where the A repeats are hypervariable and the B regions are semivariable
(21, 22). Different hypervariable A regions from different M proteins have been shown to bind
to C4b-binding protein (C4BP), plasminogen, IgA and IgG, and factor H (25). The B regions are
necessary for binding to fibrinogen and IgG (22). The highly conserved C region can also bind
factor H, as well as human serum albumin (HSA) and the host cell ligand CD46 (26, 27).
Due to its ability to interact with a number of human proteins, M protein contributes to S.
pyogenes pathogenesis in multiple ways. Through binding to components of the extracellular
matrix (ECM) such as fibronectin, it aids in adherence to epithelial cells and keratinocytes (2833). In addition, it prevents phagocytosis by binding complement-inhibitory proteins C4BP,
factor H, and factor H-like protein 1 (34-36). In vivo studies have shown that M protein is
required for full virulence in subcutaneous mouse models of invasive disease (37).

Hyaluronic capsule
Encoded by the hasABC operon, S. pyogenes expresses a hyaluronic capsule, composed
of polymers of glucuronic β-1, 3-N-acetylglucosamine (11). This capsule is structurally identical
to the hyaluronic acid expressed on host cells and connective tissue, providing protection to the
bacteria through molecular mimicry (17). Additionally, the thick capsule blocks immunological
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access to surface epitopes, inhibits host complement proteins and antimicrobial peptides, and
prevents phagocytosis (38-41). In vivo studies have shown that S. pyogenes requires capsule for
full virulence in both mouse and nonhuman primate models of invasive disease (42-46).

C5a peptidase
Encoded by the gene scpA, the C5a peptidase is a serine protease expressed on the
surface of all GAS strains (47-51). ScpA, a subtilin-like protease, is produced as a 125 kD
proenzyme, which is then cleaved to produce the active protease (11, 21, 52). The enzyme
cleaves C5a, a chemotactic peptide of the complement system that is involved in neutrophil
recruitment and stimulation (21, 53). In this manner, C5a peptidase interferes with the host
phagocyte recruitment at the site of infection. Additionally, in vivo studies using a C5a peptidase
loss of function mutant show that the mutant was deficient in colonization of the mouse
nasopharynx compared to WT (10, 54).

Streptococcal inhibitor of complement (SIC)
SIC, one of the most polymorphic bacterial proteins known, is a 31 kDa protein that
interferes with complement-mediated lysis by inhibiting the binding of the membrane attack
complex (MAC) onto bacterial cell membranes (7, 55). Given that S. pyogenes is highly resistant
to complement-mediated lysis due to its thick cell wall, the main contribution of SIC to S.
pyogenes pathogenesis is likely not interference with MAC. Rather, SIC is able to disrupt other
branches of the innate immune system including cathelicidin LL-37, α-defensins, and lysozyme
(56-58).
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Secreted virulence factors
SpeB
The cysteine protease SpeB is secreted as a 40kD zymogen, which is then
autocatalytically cleaved into a 28kD active form. SpeB is one of the most abundantly produced
virulence factors and its expression is regulated by numerous growth phase and nutritional cues,
including carbohydrate availability, NaCl concentrations, and pH (59, 60). SpeB has broadspectrum protease activity and has been shown to degrade a number of host proteins. Host targets
of its protease activity include IgG, chemokines, complement protein C3b, and ECM
components including fibrinogen (61-64). In addition, SpeB activity is responsible for cleaving
several bacterial proteins, including other virulence factors such as SPN, SLO, M protein, and
streptokinase, among others (61, 65, 66). For these reasons, the complex role of SpeB in
promoting disease is unclear and varies by strain and by animal model.

Streptokinase (Ska)
Ska is a secreted enzyme that converts plasminogen (which is coated on the surface of the
bacterial cell through the actions of several plasminogen binding M proteins (PAM)) to plasmin,
the active form of the protein (67-71). Once active, plasmin functions as a broad-spectrum serine
protease and is able to degrade blood clots, ECM components, and activate metalloproteases
(72). As S. pyogenes is strictly a human pathogen, Ska is highly specific for human plasminogen.
In vivo studies using humanized mice (transgenic for human plasminogen) have shown that Ska
and acquisition of active plasmin is necessary for dissemination of the bacteria (73).
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Superantigens
Different strains of S. pyogenes produce a variety of phage-encoded superantigens
proteins called the streptococcal pyogenic exotoxins (Spe). This family of proteins includes
SpeA, SpeC, SpeG, SpeH, SpeJ, SpeK, SpeL, streptococcal superantigen A (SSA), and the
streptococcal mitogenic exotoxin Z (SmeZ) (7). Production of these superantigens is associated
with severe bacterial diseases such as STSS and necrotizing fasciitis (7, 74). Superantigens bind
to the β-chain of CD4+ T cells and MHC class II molecules on B cells, monocytes, and dendritic
cells (7, 75, 76), thereby resulting in an overstimulation of the host inflammatory response and
production of large amounts of TNFα, IL-1β, IL-2, and IFNγ (7, 77). The release of these
cytokines results in a drop in blood pressure and multi-organ failure, the classic hallmarks of
STSS (7, 11).

Streptolysin S (SLS)
SLS is a β-hemolysin produced by the majority of S. pyogenes strains during stationary
phase growth (78, 79) and is responsible for the beta-hemolysis seen on blood-agar plates, a
classic marker for clinical identification. SLS is encoded in a highly conserved nine-gene operon
comprised of genes sagA-I (78, 79). SLS contributes to S. pyogenes pathogenesis by lysing a
large number of host cells, including lymphocytes and erythrocytes, among others (80). In vitro
data suggests that SLS contributes to pathogenesis through cytotoxicity, stimulation of host
inflammatory cells, and inhibition of phagocytosis (81). In vivo, SLS is required for full
virulence in a murine model of necrotizing soft tissue infection, as infection with an SLSdeficient mutant resulted in decreases in bacterial burden, neutrophilic inflammation, and tissue
necrosis (79).
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SPN, SLO, and Cytolysin mediated translocation

Figure 3. β-NAD+ cleavage. β-NAD+ is cleaved to form nicotinamide and ADPribose. Adapted from (1)

The streptococcal NAD+ glycohydrolase (SPN) is a 52kDa secreted protein that, when
delivered into the host cell cytosol, cleaves β-NAD+ into nicotinamide and ADP-ribose (1, 82,
83). There are two important features that make SPN’s enzymatic activity unique from other
classes of NAD+ cleaving enzymes. First, SPN has been shown to be a strict NAD+
glycohydrolase and is unable to further catalyze the products from the initial reaction (1).
Second, SPN is capable of cleaving β-NAD+ at an incredibly high rate, thus causing rapid
depletion of β-NAD+ stores within the host cell (1, 82).
Recent studies analyzing the various alleles of spn have shown that this gene is evolving
under positive selection, leading to a separation of two distinct subtypes, NADase positive which
retains the glycohydrolase activity, and an NADase negative form (82, 84). Little is known as to
the specific role of the NADase negative subtype in pathogenesis, but there is a correlation
between SPN subtypes and tissue tropism. S. pyogenes primarily causes superficial infection of
the skin or throat. Epidemiological evidence has shown that there are subpopulations of S.
pyogenes that specialize in infections at only one of these two tissue sites (skin-specialists and
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throat-specialists) (85). In addition, there is a third subpopulation that can infect both tissue types
(generalists) (85). An analysis of series of 113 clinical isolates demonstrated that skin or throat
specialists were more likely to encode the NADase negative spn allele while generalist strains
encoded the NADase positive spn allele (84). Recent work from the Caparon lab has also shown
that both NADase active and inactive forms of SPN are cytotoxic to host cells, indicating that
SPN’s contribution to S. pyogenes pathogenesis involves a secondary mechanism beyond βNAD+ depletion (82).
The spn gene is the first gene in a 3-gene operon, which also includes the genes for
immunity factor of SPN (IFS) and Streptolysin O (SLO). IFS is a small, cytosolic
protein that binds to the active site of SPN, blocking its enzymatic activity while in the

Figure 4. The spn operon. Organization of the spn operon in S. pyogenes.

bacterial cell (86). The third gene in this operon, slo, produces a cholesterol-dependent cytolysin
SLO. This protein, when secreted, contributes to pathogenesis in several ways. First, SLO
functions as a cholesterol dependent cytolysin. This class of proteins binds to cholesterol rich
areas of host membranes, oligomerizes, and inserts itself into cell membranes to form pores (87).
In this way, SLO contributes to cytotoxicity of host cells.
Secondly, a specific interaction between SPN and SLO allows for the translocation of
SPN directly into host cell cytosols (83, 88-91). This process, termed cytolysin-mediated
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translocation (CMT), involves a complex series of interactions between SPN and SLO and a
great deal of work in the Caparon lab has been performed to elucidate the mechanism behind this
delivery system. From this work, several important details have been discovered about this
process.

Figure 5. Cytolysin mediated translocation. SPN, IFS, and SLO are expressed during the
exponential phase of growth. In the bacterial cytosol, IFS binds to the SPN active site, blocking
its NADase activity. SPN and SLO are secreted through the sec machinery into the extracellular
milieu. After the bacteria adhere to the host cell, SLO monomers oligomerize and form pores in
the host cell membrane. The interaction between SPN and SLO at the membrane enables SPN to
be translocated into the host cell cytosol. Image courtesy of S. Chandrasekaran.

First, CMT is highly specific for these two proteins. Replacement of SLO with the closely
related cytolysin PFO does not allow SPN translocation (90). Second, SPN appears to be the
only substrate involved in CMT (83, 89). Additionally, it has been shown that SLO pore
formation is not necessary for SPN translocation to occur (90). Finally, recent work from our lab
has established that SPN translocation can occur through a cholesterol-insensitive mode of
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membrane binding that requires both SPN and SLO for membrane binding (91). It has also been
shown that both proteins play a role in cytotoxicity, as loss of either protein has reduced
virulence in cultured epithelial cells and in vivo in a mouse model of soft tissue infection (83,
88). Taken together, these studies demonstrate that both SPN and SLO play an important role in
the pathogenesis of S. pyogenes.

Metabolism of Streptococcus pyogenes
S. pyogenes is a member of the group Lactobacillacea or lactic acid bacteria (LAB). This
group is characterized as lacking an electron transport chain (ETC) and TCA cycle. Instead,
these bacteria rely solely on a mix of homolactic and mixed acid fermentation as a means of
generating energy in the cell (92). S pyogenes is able to utilize a number of different carbon
sources for growth, which can be obtained through several different pathways.

Carbohydrate Utilization
The majority of carbohydrates that S. pyogenes can utilize are transported into the cell
through the actions of the phosphotransferase (PTS) pathway. Like most bacteria, the preferred
carbohydrate for S. pyogenes is glucose, which can be brought into the cell and phosphorylated
via the PTS system, where it then shuttles to the Embden-Meyerhof-Parnas pathway (92, 93).
The breakdown of one glucose molecule through this pathway leads to the formation of two
molecules of ATP, NADH and pyruvate (92). Further metabolism of pyruvate via homolactic
and mixed acid fermentation allows for the re-oxidation of the NADH formed during glycolysis
(92). In the absence of glucose, S. pyogenes is able to utilize alternative carbohydrates such as
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galactose. Similar to glucose, galactose utilization begins with uptake and phosphorylation
through the PTS pathway. However, unlike glucose, the phosphorylated galactose molecule is
broken down through the tagatose pathway, leading to formation of two three-carbon sugars,
glyceraldehyde-3-phosphate (G3P) and dihydroxyacetone phosphate (DHAP) (94). From there,
these 3-carbon sugars are able to reenter the Embden-Meyerhof pathway for conversion to
pyruvate.

Homolactic and Mixed Acid Fermentation
Lacking a complete TCA cycle and ETC, S. pyogenes relies exclusively on a simple
fermentative metabolism as a means of regenerating NAD+ necessary for additional rounds of
glycolysis. The simplest and most well-known pathway for this is homolactic fermentation, the
conversion of pyruvate to lactate via the enzyme lactate dehydrogenase (LDH) (95). In this
pathway, each molecule of pyruvate is converted to lactate and one molecule of NADH is
oxidized (92, 95). The enzymatic activity of LDH is influenced by the intracellular levels of
fructose 1,6-bisphosphate, meaning that homolactic fermentation is generally only utilized when
high levels of glucose are present (92, 95, 96).
As an alternative to homolactic fermentation, S. pyogenes can also undergo mixed acid
fermentation, a pathway that begins with the conversion of pyruvate into acetyl-CoA. In
S. pyogenes this conversion is performed by the oxygen-sensitive enzyme pyruvate formate lyase
(PFL), which converts pyruvate into acetyl-CoA and formate (92, 96). PFL, in addition to being
sensitive to oxygen, is also inhibited by low intracellular levels of G3P and DHAP (92).
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Therefore, homolactic fermentation is the predominant pathway utilized by S. pyogenes in high
glucose environments. The pool of acetyl-CoA must be broken down further to regenerate
NAD+. This is achieved via the enzymes acetaldehyde dehydrogenase (ADH) and ethanol
dehydrogenase (EDH), where ethanol is the end product of the pathway (92, 96). Alternatively,
acetyl-CoA can be converted into acetate through the enzymes phosph otransacetylase (PTA)
and acetate kinase (AckA). Although the PTA/AckA pathway does not allow for the oxidation of
NADH, it does produce one molecule of ATP (92, 96). In this way, mixed acid fermentation
enables the cell to balance its redox neutrality, as well as benefit from an additional source of
ATP.

Figure	
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Metabolism of Alternative Carbon Sources
Within the group of LAB, several pathways are present for the catabolism of various
amino acids. In S. pyogenes the arginine deiminase (ADI) pathway has been shown to benefit the
bacterium in several different capacities. This pathway enables the conversion of arginine to
ornithine, ammonia, carbon dioxide, and one molecule of ATP (97, 98). Studies have shown that
arginine can be utilized by the bacterium for growth, and that the production of ammonia acts as
a buffering agent to counter the acid stress, which is a consequence of mixed acid fermentation
(98, 99). Additionally, recent work from the Caparon lab has shown that the ADI pathway
contributes to pathogenesis in a murine model of inflammatory infection of cutaneous tissue
(99). It was shown that infection with S. pyogenes stimulates iNOS expression in cultured
macrophages and that this innate immune response could be modulated by the availability of
arginine. Therefore, the depletion of arginine via ArcA (the first enzyme involved in the ADI
pathway) prevents production of NO , allowing for enhanced virulence of S. pyogenes.

Transcriptional regulation in Streptococcus pyogenes
The ability of S. pyogenes to colonize and persist within its human host is dependent
upon its capacity to acquire nutrients from the surrounding environment while evading host
immune factors. The infection cycle of this pathogen begins with the initial colonization of the
skin or throat, penetration into subcutaneous tissues, and, in the case of invasive disease,
dissemination through the blood to secondary sites of infection (100). To survive and persist
within each location the bacterium needs to adjust to numerous changes in the environment such
as glucose levels, protein concentrations, pH, osmolarity, and temperature (100-102).
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Throughout this infection cycle the bacterium must also negotiate a delicate balance between the
damage inflicted on the host as a result of the virulence factors being produced and the immune
response that this damage induces. Analysis of transcriptome changes of several bacterial
pathogens throughout their infection cycle has suggested that careful spatial and temporal
expression of virulence factors is important to the overall success of the pathogen’s survival
(103). Toxin production enables the bacterium to gain access to nutrients within the tissue, with
cell damage being a side effect of their production. As a result, a certain level of tissue damage,
and therefore immune stimulation, must occur, however, excessive toxin production could prove
to be detrimental to the bacterium because of the immune response that is triggered.

Figure 7. S. pyogenes virulence factors are expressed in a tightly regulated temporal and spatial
pattern. (A) Virulence factors involved in adherence and host immune evasion are necessary during the
initial stages of infection. (B) During the middle stages antiphagocytic factors such as M protein and
hyaluronic capsule are highly expressed. (C) During an invasive infection numerous surface-bound and
secreted virulence factors are expressed that cause direct damage to host tissue. Adapted from (10).

While S. pyogenes lacks alternative sigma factors, it encodes a number of two-component
systems (TCS) and stand-alone response regulators that control global gene expression in
response to numerous physical and environmental signals (4, 101, 104-111). The following
sections will explore several of the most well characterized of these transcriptional regulators.
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CovRS
The S. pyogenes genome contains 13 different TCSs (3, 11, 105) that are made up of a
sensor histidine kinase (HK) and its corresponding response regulator (RR) (see Figure 8). The
HK protein has an extracellular sensor domain and a cytosolic kinase domain, which are linked
together by the protein’s transmembrane domain. When a
signal (or substrate) interacts with the sensor domain of the
HK, this triggers activation of the autokinase domain, leading
to autophosphorylation of the protein at a conserved histidine
residue in the cytosolic domain. From there, the phosphate
gets transferred directly to a conserved aspartate residue on
the RR, leading to its activation as a DNA binding protein
(112). This form of transcriptional regulation is very
common in bacteria, as it allows for the cell to rapidly
Figure 8. Bacterial two-component
system (TCS).

adapt to a particular environmental signal by altering the
expression of a specific subset of genes.

Of the 13 identified TCS encoded by S. pyogenes, the control of virulence regulatory
system (CovRS) is the best characterized. In this system, CovS acts as the sensor HK and CovR
is its reciprocal RR (3, 11, 105). The function of the CovRS TCS is thought to mostly control
genes involved in general stress response. Numerous environmental signals have been shown to
trigger CovRS activation including increased temperature, low pH, high salt concentrations, high
Mg2+ levels, LL-37, and iron starvation (105, 113-115). The covRS regulon includes up to 15% of
the total genes in S. pyogenes and has been shown to be essential for survival in various stress
conditions (2, 113, 116, 117).
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CovR acts largely as a repressor of gene expression and is thought to bind and repress
genes in both a phosphorylated and a nonphosphorylated state (118). It has been hypothesized
that CovR acts on one subset of its regulon when phosphorylated and another subset of genes
when in a nonphosphorylated state (118). The CovRS regulon includes a significant number of
known virulence factors such as SpeB, Ska, SPN, SLO, Ig-degrading enzymes, and DNases,
among others (116, 119). An important thing to note is that while CovRS acts as a repressor for
most virulence factors, it is an activator for SpeB expression (11, 116).

Figure	
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  in	
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  and	
  adaptation.	
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Strains incurring mutations leading to inactivation of either CovR or CovS are associated
with hypervirulence in mice and invasive disease (11, 116, 120). This is likely due to the
overexpression of numerous virulence factors that aid in tissue destruction and immune evasion
(116, 121). In particular, covRS mutants are highly resistant to phagocytosis and neutrophil
killing due to high productions of hyaluronic capsule, SIC, SpeA, Ska, and C5a peptidase (116).
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Figure 10. Model for dissemination of CovRS mutants. Spontaneous mutations in the covRS
operon during invasion of subepithelial tissue can lead to enhanced resistance to neutrophil killing.
These resistant mutants can then go on to invade deeper tissue, leading to systemic infection.
Adapted from (3).

Mga
In addition to its 13 TCS, S. pyogenes encodes several stand-alone response regulators.
One of the most well characterized of the stand-alone response regulators in S. pyogenes, Mga is
a global transcriptional regulator and is responsible for positive regulation of target genes during
exponential growth (11, 101, 109). Although the mga gene is present in all serotypes, there are
two allelic variants of the gene. These variants have been linked to tissue tropism, where the
mga-1 allele is found mostly in throat-specialists and mga-2 is associated with skin- specialists or
“generalists” (85, 109).
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Numerous growth phase and environmental signals are associated with Mga regulation
including CO2, temperature, and iron levels (122-124). Recent work has demonstrated that
phosphorylation and inactivation of Mga can occur through interactions with proteins of the
phosphotransferase system (PTS) (125, 126). This information provides a direct link between
sugar metabolism and Mga activity.
Mga is associated with controlling expression of genes involved in colonization of host
tissue and immune evasion. Genes directly activated by Mga (i.e. Mga directly binds to the
promoters of these targets) are referred to as the “core” Mga regulon. Target genes within this
group include adhesins (such as M protein, M-like proteins, fibronectin- and collagen-binding
proteins), immune modulators (C5a peptidase, SIC, and Ig-binding proteins), and the mga gene
itself (101, 106, 126). Beyond this core set, there are numerous other target genes whose
expression is indirectly affected by Mga. These indirect targets can include virulence factors
such as the hasABC capsule synthesis locus and speB, as well as genes involved in metabolism
such as several PTS genes (106, 127). Additionally, there is a large amount of variation within
the Mga regulon, indicating a significant amount of strain-specific regulation (109, 127). Since
Mga is involved in the activation of several of the major S. pyogenes virulence factors, its role in
virulence has been studied in detail. It has been shown that loss of mga results in defects in
adherence to host cells, as well as an attenuation of virulence in murine models of invasive
disease (128-131).

RopB
Another well-characterized stand-alone response regulator in S. pyogenes is RopB, first
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identified as a positive regulator of the secreted virulence factor SpeB (132). Regulation by
RopB is linked to growth phase, controlling gene expression during stationary phase of growth
(101, 133, 134). Analyses of the role of RopB in transcriptional regulation has shown that
deletion of this regulator has a pleiotropic effect, altering the expression of genes involved in
virulence, metabolism, and stress response among others (135-138). This varied response is
likely, in part, an indirect effect, as RopB itself is a regulator of a number of uncharacterized
transcriptional regulators (133, 139). Further complicating the role of RopB regulation in S.
pyogenes is the fact that there is a great deal of strain specificity in the RopB regulon, with speB
being one of the few genes that is consistently controlled by this regulator in multiple strains
(133, 136).
Currently, the mechanism of activation for RopB is also unclear. RopB is classified as a
member of the Rgg family of transcriptional regulators. In Gram-positive bacteria, this family is
associated with quorum sensing via interactions with oligopeptide pheromones (133). However,
no evidence has been reported to indicate that RopB is involved in a quorum sensing mechanism
(133). Finally, the contribution of RopB to S. pyogenes pathogenesis is also unclear at this time.
Despite both direct and indirect regulation of numerous virulence factors, there have been
conflicting reports on the effects of RopB inactivation on virulence (135, 138, 140). These
results are, at least partially, the result of the strain-specific nature of the RopB regulon (133).

CcpA
In Gram-positive bacteria, carbon catabolite repression (CCR) is largely under the control
of the transcriptional repressor CcpA. CCR ensures that the bacterial cell maximize its fitness
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through the hierarchical utilization of carbon sources (141-143). In the presence of a preferred
carbon source such as glucose, the molecule will be rapidly taken into the cell and degraded
through the glycolytic pathway, leading to high intracellular concentrations of fructosebisphosphate (FBP). The fluctuation of this metabolic intermediate affects the enzymatic activity
of the protein HprK.
HprK, a protein found exclusively in Gram-positive bacteria, is a dual kinase/phosphatase
whose role is to control the phosphorylation of the PTS protein HPr (142-144). In Grampositives, HPr can be phosphorylated on either of two conserved residues. HprK controls
phosphorylation of HPr on a specific serine residue, Ser46 in S. pyogenes (143, 145). At high
FBP concentrations, HprK functions as a kinase, phosphorylating HPr at Ser46. This P~Ser-HPr
acts as a cofactor for CcpA, binding to the CcpA dimer and inducing a structural change that is
required for CcpA to bind target promoter DNA (146). When in its active conformation, CcpA
will bind to catabolic-responsive elements (cre) sites, acting largely as a repressor of gene
expression (144, 146).
CcpA has been shown to control up to 20% of the total genome of S. pyogenes. Global
transcriptional analysis of the CcpA regulon has shown that, in addition to controlling alternative
catabolic operons, it controls expression of a number of virulence factors including speB, sagA,
and cfa (147, 148). Additionally, although a significant portion of the CcpA regulon includes
glucose-regulated genes, there is a subset of genes that appear to be regulated by CcpA
independently of glucose concentrations (148). This information suggests that there is a second,
currently unknown, catabolite-sensing pathway involved in CcpA regulation.
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LacD.1
LacD.1 was identified initially through a genetic screen as a negative regulator of the
cysteine protease SpeB. It was determined that this protein repressed SpeB expression in
response to neutral pH, high salt concentrations, and carbohydrate availability (60, 149). LacD.1
is annotated as a tagatose bisphosphate aldolase, an enzyme involved in the catabolism of lactose
and galactose (150). In S. pyogenes there are two Lac loci, Lac1 (which includes LacD.1) and
Lac2 (149, 151). The lac1 locus contains several truncated genes, making it unable to utilize
lactose and galactose, but has evolved into a regulatory locus via LacD.1 (151). Conversely, the
Lac2 locus has maintained full-length genes and is able to utilize lactose and galactose, but does
not have any reported regulatory activity (151).
The specific mechanism that LacD.1 uses to regulate genes remains unclear, but it has
been shown that this protein does not require its enzymatic activity for this regulation (149). It
does, however, require the ability to bind to the glycolytic intermediates G3P and DHAP (149).
This information has led to the hypothesis that LacD.1 functions to regulate genes in response to
carbohydrate availability. Further indication of this includes the fact that a significant number of
genes in S. pyogenes that are regulated by glucose levels are also part of the LacD.1 regulon
(148). These include virulence genes like SpeB, as well as genes involved in various metabolic
processes (148).

CodY
The global transcriptional regulator CodY is involved in controlling gene expression in
response to amino acid starvation (102, 152, 153). CodY, which has been shown to control 17%
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of the total genome through direct and indirect regulation, is activated by high levels of GTP and
branched chain amino acids (BCAA) (102, 111). In the presence of high concentrations of these
substrates, CodY is able to bind to DNA target promoters with high affinity, leading to
repression of target genes. Conversely, when these substrates are present in low levels, as would
be expected during starvation conditions, CodY is inactivated, leading to enhanced transcription
of the CodY regulon. Genes identified as being regulated by CodY include transcriptional
regulators such as covRS, mga, and codY itself (152). Additionally, numerous virulence factors
are repressed by CodY including DNases, M protein, capsule synthesis, cytolysins SLO and
SLS, and several proteases, among others (152, 153). This has led to the hypothesis that the main
function of CodY is to alleviate starvation by allowing the bacterial cell to produce proteins that
can aid in dissemination and macromolecular breakdown, thus providing the bacteria access to
additional sources of nutrients during an infection (111, 153)
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Aim and Scope of Thesis
The aim of this thesis was to provide insights into the convergence of metabolism and
virulence in the pathogenic bacterium Streptococcus pyogenes. In particular, we sought to
identify regulatory mechanisms utilized by Streptococcus pyogenes in response to remodeling of
its local tissue environment during an infection. As a lactic acid bacterium, S. pyogenes utilizes a
mix of homolactic and mixed acid fermentation to produce energy in the cell. As a result, several
organic end products are produced and secreted, thus affecting the pH of the surrounding
environment. In order for the bacteria to survive over time, it must adapt to late stage conditions
of low pH and glucose depletion. Although it has been established that both carbohydrate
availability and environmental pH are triggers for global transcriptome remodeling in this
bacterium, the specific regulatory pathways controlling these transcriptional responses are
largely unknown.
To that end, the work presented here will characterize several novel mechanisms by
which S. pyogenes is able to adapt to its self-induced acid stress and carbohydrate depletion. The
research in this thesis will describe two separate regulatory systems, one controlling an
alternative catabolic pathway and one controlling an important pair of cytotoxic proteins, both of
which are controlled by environmental pH. Taken together, this work provides greater insight
into adaptive mechanisms utilized by S. pyogenes during late stages of growth.
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SUMMARY
The ability of Streptococcus pyogenes to infect different niches within its human host
most likely relies on its ability to utilize alternative carbon sources. In examining this question,
we discovered that all sequenced S. pyogenes strains possess the genes for the malic enzyme
(ME) pathway, which allows malate to be used as a supplemental carbon source for growth. ME
is comprised of four genes in two adjacent operons, with the regulatory two-component MaeKR
required for expression of genes encoding a malate permease (maeP) and malic enzyme (maeE).
Analysis of transcription indicated that expression of maeP and maeE are induced by both malate
and low pH, and induction in response to both cues is dependent on the MaeK sensor-kinase.
Furthermore, both maePE and maeKR are repressed by glucose, which occurs via a CcpAindependent mechanism. Additionally, malate utilization requires the PTS transporter EI enzyme
(PtsI), as a PtsI- mutant fails to express the ME genes and is unable to utilize malate. Virulence
of selected ME mutants was assessed in a murine model of soft tissue infection. MaeP-, MaeK-,
and MaeR- mutants were attenuated for virulence, whereas a MaeE- mutant showed enhanced
virulence as compared to wild type. Taken together, these data show that ME contributes to S.
pyogenes’ carbon source repertory, that malate utilization is a highly regulated process, and that
a single regulator controls ME expression in response to diverse signals. Furthermore, malate
uptake and utilization contribute to the adaptive pH response and ME can influence the outcome
of infection.
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INTRODUCTION
Although it has a relatively small genome (approx. 1.8 Mbp), the pathogenic Gram-positive
bacterium Streptococcus pyogenes has a remarkable ability to adapt to a variety of human
tissues. This trait allows it to cause numerous diseases ranging from superficial and self-limiting
infections in soft tissues like the skin (impetigo) and pharynx (pharyngitis) to more problematic
infections at a number of diverse anatomical sites (1). Understanding the complex regulatory
interactions that allow it to adapt to these diverse environments provides a unique opportunity to
gain insight into how a pathogen can efficiently employ a relatively limited genetic repertory to
maximize its ability to cause disease.
An important question is how S. pyogenes uses its limited metabolic potential to grow
efficiently in diverse tissues. Considerable evidence has accrued to suggest that the patterns by
which S. pyogenes exploits available growth substrates are intimately associated with both
temporal and compartment-specific patterns of virulence gene expression (2-4). As a lactic acid
bacterium, S. pyogenes relies exclusively on fermentation via the homo-lactic and mixed acid
pathways to generate energy (5-7). However, the specific carbon sources it preferentially utilizes
in different tissues, the temporal patterns with which these are consumed, and how these patterns
impact regulation of virulence gene expression are not well understood.
One approach to gain insight into conditions encountered during infection has involved
comparison of the S. pyogenes transcriptome between organisms recovered from various models
of infection to organisms cultured under different in vitro conditions. In general, these studies
have revealed that at the latter time points of infection, patterns of gene expression most closely
resemble those observed in vitro in environments of low pH (pH 6.0-6.5) and low concentrations
of glucose (8-10). These two conditions are likely related, as the fermentation of glucose by
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lactic acid bacteria results in the highest rates of production of acidic end products including
lactate, acetate and formate (6, 7). This suggests that S. pyogenes’ choice of carbon source results
in a significant remodeling of its local tissue environment. It also indicates that over the course
of infection, it must both adapt to its self-inflicted acid stress as well as exploit alternative carbon
sources. In this regard, transcriptome profiling revealed that one of the most highly differentially
activated gene clusters under conditions of acid stress, glucose starvation, and in murine soft
tissue encodes a putative operon of two genes predicted to function in the catabolism of malate
(10), annotated as the malic permease (maeP) and the malic enzyme (maeE) (Fig. 1A).
The di-carboxylic organic acid malate is found in abundance in tissue and in the
environment, so it is not surprising that numerous malate degradation pathways have been
identified among both prokaryotic and eukaryotic organisms (11-17). In lactic acid bacteria, two
distinct pathways have been identified that make very different contributions to physiology. The
most common of these is malolactic fermentation (MLF), which allows for the conversion of
malate into lactate through the function of the malolactic enzyme (MLE). Typically, MLF does
not contribute to growth yields, but does play an important role in maintenance of ATP pools
during starvation and in protection from acid killing (18-21). Since malate is a stronger acid than
lactate, its decarboxylation by MLF results in alkalization of the cytoplasm and the resulting pH
gradient drives the malate/lactate antiporter coupled to ATP synthesis (7, 18-21).
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Figure 1. The malic enzyme (ME) pathway in S. pyogenes. (A) The arrangement of the
open reading frames that comprise the ME locus of S. pyogenes are shown by large arrows.
Gene names are shown below and the genomic loci listed within the open reading frames are
based on the genome of S. pyogenes HSC5 (23). Known (black font) and predicted (grey
font) regulatory elements of the intergenic region of S. pyogenes and Enterococcus faecalis
JH2-2 (Ef JH2-2, (58)) and Lactobacillus casei BL23 (Lc BL23, (15)) are shown below.
Arrows indicate sites in DNA bound by MaeR, while sites bound by CcpA are boxes labeled
“cre” (catabolite regulatory element). Numbers below indicate intergenic distances in
numbers of base-pairs. (B) Schematic of the ME pathway. The subcellular localization,
function and reactions catalyzed by the various components of the ME pathway that are
listed in the Figure are shown.

	
  
	
  

51	
  

Less commonly found is an alternative degradation pathway that converts malate to pyruvate
and carbon dioxide (18) that is known as the malic enzyme (ME) pathway (Fig. 1B). A unique
feature of ME is that, unlike MLF, it enables cells to utilize malate as a carbon source for growth
(16, 18). However, while the MLF system has been extensively studied, the regulation and
physiological significance of the ME pathway is not as well understood. Studies in several lactic
acid species, including Enterococcus faecalis, Streptococcus bovis, and Lactobacillus casei (13,
15, 17, 22), have indicated that ME requires 4 genes organized into two adjacent operons (Fig.
1A). These include the maePE operon that encodes the transmembrane permease (maeP) and
cytosolic malic enzyme (maeE). Expression of these genes is dependent on the adjacent twocomponent system (TCS), which includes a sensor histidine kinase (maeK) and response
regulator (maeR) (15, 17, 18).

This similar organization is observed in the S. pyogenes

chromosome (Fig. 1A), and as noted above, maePE is upregulated by acid stress and infection in
S. pyogenes. In addition, examination of the S. pyogenes profiling data shows that both the
maePE operon and the adjacent TCS had similar patterns of regulation, suggesting that these two
systems function together (10).
Interestingly, while other ME operons are activated by malate (15, 17, 18) and repressed by
glucose (15, 17), regulation by pH has only been described for Lactobacillus casei (18). Whether
this system is regulated by pH in other bacterial species that contain a functional ME pathway,
and the physiological role of this regulation is not understood. Rather, pH regulation is more
commonly associated with the MLF pathway, where it is associated with acid resistance (20, 21).
Examination of the S. pyogenes genome has not revealed the presence of MLF genes (23) so the
significance of pH regulation of the ME pathway and whether it compensates for MLF in acid
tolerance is not clear. In this study, we examined the contribution of malate catabolism and its
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unique pattern of regulation to S. pyogenes physiology and virulence. This analysis revealed that
S. pyogenes has a functional ME pathway, that catabolism of malate contributes to growth and
that its regulation shares some similarities with other lactic acid bacteria, but also has several
unique features. Finally, we show that the presence or absence of ME genes can influence
virulence in a murine model of soft tissue infection.
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RESULTS
ME is necessary for S. pyogenes malate-enhanced growth. It is unclear why the ME pathway
in S. pyogenes is regulated by pH, as MLF and not ME is typically associated with acid-stress
resistance in other lactic acid species (20, 21). However, S. pyogenes lacks the genes necessary
for MLF (23), so the contribution of the ME pathway to streptococcal physiology was
investigated. The malic enzyme uses NAD+ to oxidize malate to produce CO2, NADH and
pyruvate (Fig. 1B). Since pyruvate can be further metabolized to produce ATP, the signature
function of ME is to allow cells to utilize malate as a carbon source for growth (16). To test this
growth phenotype, S. pyogenes HSC5 was cultured overnight in a carbohydrate-reduced medium
(C medium) in the presence or absence of 0.5% malate. Although cultures had comparable
growth rates in both conditions (t1/2 = 56 min. and 63 min., respectively), 0.5% malate enhanced
growth yields by approximately 50% (Fig. 2A). Additionally, pH measurements of cell-free
supernatants taken throughout growth indicate that malate utilization does not alter the pH of the
media compared to unmodified C medium (Fig. S2A). This is due to the fact that, unlike when
grown in media supplemented with glucose, when grown on malate, the bacteria utilize mixed
acid fermentation, producing large amounts of formate, which has a much higher pKa than the
lactate commonly produced (Fig. S2B).
In-frame deletion mutants in maeP (malate permease), maeE (malic enzyme), maeK
(malate sensor kinase), and maeR (malate response regulator) were constructed and were found
to have identical growth characteristics to wild type in unmodified C medium. However, all
mutants failed to shown an increased growth yield the in the presence of malate (Fig. 2B).
Malate concentrations were measured from cell-free
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Figure 2. ME mutants are deficient in malate catabolism. (A) WT bacteria were tested for
malate utilization by measuring growth over the course of 16 hrs of cultures grown in either
unmodified C medium or C medium supplemented with 0.5% malate. Data are presented as
means and standard deviations from 3 independent experiments. (B and D) WT and ME mutants
were grown in unmodified C medium or C medium supplemented with 0.5% malate. Following
16 hrs of incubation, growth yields were measured by OD600. Data are presented as the means
and standard deviations from 3 independent experiments. (C and E) Malate concentrations from
cell-free culture supernatants from over-night cultures of WT or ME mutants grown in C medium
supplemented with 0.5% malate were measured (see Methods). Data are presented as percent
remaining (compared to initial concentration) and are represented as means and standard
deviations from 3 biological samples analyzed in duplicate. Asterisks indicate significant
differences (***, P < .001) compared to WT in C medium.
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supernatants of overnight cultures grown in 0.5% malate to determine malate consumption by
wild type (WT) and the four ME mutants. WT cultures exhibited an approximately 80%
reduction from the initial concentration of 37.3 mM, while malate concentrations were
unchanged by growth of the mutants (Fig. 2C). With the exception of maeE, it was not possible
to express the ME genes from a plasmid for complementation. As an alternative, allelic
replacement was used to restore the full-length maeK gene in a ∆MaeK mutant background to
make the reversion strain MaeKR. In this way, we were able to complement at least one gene
from each operon. Complementation of maeE and reversion of maeK restored both enhanced
growth yields in the presence of malate (Fig. 2D) and consumption of malate (Fig. 2E).

Expression of ME genes is dependent on malate and requires MaeK. In other lactic acid
bacteria, expression of ME requires both the presence of malate and the ME TCS (15, 17, 18).
To determine if this common regulatory mechanism is also utilized in S. pyogenes an analysis of
transcript levels of ME genes using real time RT-PCR was performed. The results indicated that
during the exponential phase of growth (OD600 = 0.2), maeE and maeP were highly upregulated
in the presence of malate by 100- and 200-fold, respectively (Fig. 3A). This response was
dependent on MaeK, as transcript levels were equivalent in the presence or absence of malate.
Restoration of the protein in a MaeKR reversion strain also restored malate induced transcription
(3A). Transcription of maeK and maeR was also increased in the presence of malate in WT cells,
with both genes showing an approximately 3-fold increase compared to unmodified media (Fig.
3B).
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Figure 3. MaeK regulates malate-dependent expression of maePE. (A) WT, MaeK-, and
MaeKR strains were grown in C medium supplemented with 0.5% malate until exponential
phase (OD600 of 0.2). Total RNA was isolated and used for real time RT-PCR analysis of
maeP and maeE transcripts. (B) WT bacteria were grown in C medium supplemented with
0.5% malate as described before. Total RNA was isolated and used for real-time RT-PCR
analysis of maeK and maeR transcripts. Data presented for all genes are the ratios of
transcript abundance in modified medium to that of unmodified C medium and represent the
means and standard deviations of 3 biological samples, each analyzed in triplicate.

Glucose regulation of ME is CcpA-independent. Malate catabolism in other lactic acid
bacteria is repressed by glucose, indicating this pathway is regulated through a mechanism of
carbon catabolite repression (CCR) (15, 17). CCR allows the bacteria to metabolize preferable
carbon sources in the environment, usually through transcriptional repression of genes involved
in the processing of alternative, and less favorable carbon sources (reviewed in (35-37)). A key
transcriptional regulator of global CCR in Gram-positive bacteria is CcpA (35), which has been
shown to regulate ME in response to glucose in both Lactobacillus casei and Enterococcus
faecalis (15, 17). To test for CCR regulation of the ME pathway in S. pyogenes, transcription of
the four ME genes was analyzed in the absence or presence of glucose (0.2%) by real time RTPCR. Results showed a significant repression of 4-6-fold (log2 scale) for all four ME genes (Fig.
4), consistent with observations in other lactic acid species (15, 17). However, in contrast to
these other species, repression occurred independently of CcpA, as the addition of glucose still
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repressed expression of all ME genes in a CcpA- mutant (Fig. 4) (38). Repression does have the
characteristics of CCR, as glucose was repressive even in the presence of malate (Fig. 4),
indicating that S. pyogenes has adopted a CcpA-independent CCR mechanism for regulation of
malate catabolism.
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Figure 4. Carbon catabolite repression of ME genes is CcpA independent. WT
and CcpA - bacteria were grown in C medium supplemented with 0.2% glucose until
exponential phase (OD600 of 0.2). Total RNA was isolated and used for real-time RTPCR analysis of the individual mae transcripts. Data are presented as the ratios of
transcript abundance in modified media to that in unmodified C medium and
represent the means and standard deviations derived from 4 biological samples, each
analyzed in triplicate.
	
  

Malate catabolism is regulated by PTS-mediated phosphorylation. An alternative mechanism
of CCR in bacteria is known as induction prevention, which is dependent on the sugar
phosphotransferase (PTS) system and the phosphorylation state of a conserved histidine residue
of the phosphocarrier protein HPr (36), which in the case of S. pyogenes is His15 (39). If the ME
loci are controlled by a mechanism similar to induction prevention, then cells unable to produce
P~His-HPr should be unable to utilize malate. To test this hypothesis, two mutants were
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constructed. The first is an allelic exchange mutant with a swap of a chloramphenicol cassette
with ptsI, which encodes EI, the enzyme responsible for phosphorylation of the His15 site within
the HPr protein. The second mutant contains a single amino-acid substitution in HPr, replacing
His15 with alanine, which has been shown to maintain HPr capability to be phosphorylated at
Ser46 and is functional for sugar transport, but lacking in the ability to participate in regulation
(HPrH15A) (36, 40, 41).
When grown in the presence of malate, both the PtsI- mutant and the HPrH15A mutant have
a significant growth defect compared to WT, resulting in a reduced growth rate and lower final
culture density (Fig. 5A and 5B). To verify that this growth defect was specific for malate
utilization and not a general defect in all conditions, strains were also grown in unmodified C
medium, as well as in C medium supplemented with 0.2% maltose (a non-PTS sugar) (34).
Comparisons of final yield from overnight cultures demonstrate that growth of both the PtsI- and
HPrH15A mutants are similar to WT in unmodified media (Fig. 5B). In addition, upon
supplementation of maltose, all three strains showed an identical increase in growth (Fig. 5B).
Thus, mutations that block formation of P~His-HPr are deficient in malate utilization, but are
still able to utilize non-PTS carbon sources.
Expression of the ME genes was then examined in the presence of malate and it was
discovered that when compared to WT, the HPrH15A mutant had a substantial reduction in
transcript levels for all four ME genes (Fig 5C). Taken together, these data demonstrate that the
ME pathway in S. pyogenes is repressed by glucose through a mechanism similar to induction
prevention.
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Figure 5. Carbon catabolite
repression of ME genes controlled
by P~His-HPr. WT, PtsI-, and HPr
H15A
strains were grown in
unmodified C medium or C medium
plus 0.5% malate. (A) Growth of
WT and PTS mutants in malatesupplemented
medium
was
measured by OD600 over the course
of 16 hrs. Data presented is from a
representative experiment. (B) WT
and PTS mutants were grown in
unmodified C medium or C medium
supplemented with 0.5% malate.
Following 16 hrs of incubation,
growth yields were measured by
OD600. Data are presented as the
means and standard deviations from
3
independent
experiments.
Asterisks
indicate
significant
differences (*, P < .05) compared to
WT in C medium. (C) WT and
HPrH15A strains were grown in C
medium supplemented with 0.5%
malate until exponential phase
(OD600 of 0.2). Total RNA was
isolated and used for real-time RTPCR
analysis
of
transcript
abundance of the individual mae
transcripts. Data are presented as
ratios of transcript abundance of
HPrH15A to that of WT and represent
the means and standard deviations
derived from 3 biological samples,
analyzed in triplicate.
	
  

pH regulation of ME is independent of malate, but dependent on maeK. Prior transcriptional
profiling revealed that maeP and maeE are among the genes most highly regulated by pH in S.
pyogenes (10). Additionally, growth of WT cells in acidified media was enhanced with the
addition of malate, demonstrating that malate catabolism can occur in a low pH environment
(Fig. S3). To further characterize the role of environmental pH on the ME pathway, WT S.
pyogenes was grown in C medium buffered to either low (pH 6.0) or neutral (pH 7.5) pH and
transcription of the ME genes was analyzed by real time RT-PCR. When compared to
unbuffered medium and in the absence of the addition of malate, growth at low pH, but not
neutral pH, enhanced abundance of the maeP and maeE transcripts by approximately 10- and 20fold, respectively (Fig. 6A). Neither low nor high pH environments altered expression of maeK
or maeR when compared with unmodified media (Fig. 6B). However, MaeK itself was required
for the enhanced expression of maeP and maeE, as the abundance of these transcripts did not
increase in the MaeK- mutant during growth at low pH, but regulation was restored in the MaeKR
strain (Fig. 6C). Finally, to address the hierarchy of stimuli between malate and pH, quantitative
RT-PCR was performed on cells in the presence of both high malate (0.5%) concentrations and
neutral pH and compared to malate alone. Results show that, for both maeP and maeE,
transcription is dramatically increased in the presence of 0.5% malate, and that this enhanced
expression is unaffected by the pH of the media (Fig. 6D). Overall, this data shows that mae gene
expression is regulated by environmental pH, and that this regulation is mediated through MaeK
and is independent of malate regulation.
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Figure 6. pH regulation of ME is malate-independent, but requires MaeK. (A) WT bacteria were
grown in C medium buffered to pH 6.0 or pH 7.5 until exponential phase (OD600 of 0.2). Total RNA
was isolated and used for real-time RT-PCR analysis of the individual mae transcripts. Data are
presented as the ratios of transcript abundance in buffered media to that in unmodified C medium and
represent the means and standard deviations derived from 3 biological samples, each analyzed in
triplicate. (B) WT, MaeK-, and MaeKR strains were grown in C medium pH 6.0 and total RNA was
isolated as described before and used for real-time RT-PCR analysis of maeP and maeE transcripts.
Data are presented as ratios of transcript abundance in buffered media to that in unmodified C medium
and represent the means and standard deviations derived from 3 biological samples, each analyzed in
triplicate. (C) WT bacteria were grown in C medium plus 0.5% malate or C medium plus 0.5% malate
buffered to pH 7.5 and total RNA was isolated as described before and used for real-time RT-PCR
analysis of maeP and maeE transcripts. Data are presented as ratios of transcript abundance in modified
medium to that in unmodified C medium and represents the means and standard deviations derived
from 3 biological samples, each analyzed in triplicate.
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Loss of MaeE causes enhanced virulence in vivo. The in vitro experiments presented in this
work were done with bacterial cultures grown in C medium, which is characterized as having
low carbohydrate concentrations and high salt and peptide levels (10). It has been demonstrated
previously that these conditions are highly analogous to the in vivo milieu of carbon sources
within the murine soft tissue environment (10). Additionally, malate, being one of the
intermediate products of the citric acid cycle, is abundant in host tissue (42). Therefore, the fact
that S. pyogenes is able to utilize malate in vitro when added to C medium lends strong support
that it can also be utilized in vivo during host tissue infections.
Thus, it was of interest to determine if malate utilization and the ME pathway play a role
in virulence. To assess this, a murine soft tissue model was used. Briefly, approximately 107
bacteria were injected subcutaneously into the flank of immunocompetent hairless mice.
Infection of WT S. pyogenes HSC5 produces a localized necrotic lesion and formation of an
escher within 24 hours, but does not cause a systemic infection (33). Lesion size increases over
time, peaking in size at day 3 post-infection (32). Measurement of the lesion area over time is
therefore used as a marker for virulence in this model. For this analysis, mice were infected with
WT, MaeP-, MaeE-, MaeK-, or MaeR- strains and lesion areas were compared 3 days postinfection. Mice infected with strains MaeK-, MaeR-, and MaeP- all formed lesions that were
significantly smaller than WT (Fig. 7). Conversely, mice infected with the MaeE- strain formed
lesions that were significantly larger than WT (Fig. 7). These results demonstrate that malate
catabolism is an important factor during a soft tissue infection, and that the loss of individual ME
genes can have differential effects on the outcome of an infection.
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Figure 7. Loss of MaeE causes hypervirulence in vivo. Hairless SKH1 mice were infected subcutaneously with
WT or individual ME mutant strains and the resulting lesions formed at day 3 post-infection were measured. Each
symbol plotted represents the value derived from an individual animal. Data shown are pooled from at least 2
independent experiments with the mean and standard deviation indicated. Differences between groups were tested
for significance using the Mann-Whitney U test (* P < 0.05, ** P < 0.01).

	
  
	
  

64	
  

DISCUSSION
In this study we have shown that the ME genes of S. pyogenes allow the bacterium to use
malate as a carbon source for growth. Additionally, we have shown that this pathway is
subjected to regulation by both positive and negative signals, including glucose, malate, and pH.
The former of these is via PTS-mediated phosphorylation, while the latter two signals are
recognized by the MaeKR regulatory system. Finally, these data show that loss of any individual
mae gene can alter the outcome of a soft tissue infection in mice, suggesting that the ability to
transport and utilize malate are both key processes in pathogenesis.
Regulation of ME gene expression in S. pyogenes was found to share features in common
with other bacterial species (15, 17, 18). Most notably is that they are induced by malate and that
induction requires the MaeKR TCS. A prior analysis of the maePE and maeKR promoter regions
in L. casei identified the DNA-binding site for MaeR as a series of direct repeats and a similar
site is shared among other lactic acid bacteria, including S. pyogenes (Fig. S1) (15, 17). Another
common feature to ME pathway regulation is that all species repress ME gene expression in the
presence of glucose, a regulatory mechanism known as carbon catabolite repression (CCR) (36,
37, 43). However, in S. pyogenes, glucose-mediated regulation of the ME loci functions
independently of the major carbon catabolite protein CcpA. In support of this finding is the fact
that, unlike the other characterized lactic acid bacteria, the promoter region in S. pyogenes lacks
any identifiable cre sites (Fig. 1, Fig. S1) (15, 35, 43, 44).
Instead, an alternative method of CCR, induction prevention, is likely regulating ME
genes in S. pyogenes. Evidence to support this idea includes the fact that multiple genetic strains
that are unable to form P~His-HPr (either through loss of the EI enzyme or direct mutation of
HPr) are likewise deficient in ME transcription and malate utilization. This method of regulation,
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therefore, enables the cell to activate ME genes only in the presence of a high concentration of
P~His-HPr. During normal growth utilizing preferred carbohydrates, levels of intracellular
P~His-HPr would likely be low (36, 45). This is due to either rapid accumulation of P~Ser-HPr
or transfer of the phosphate group on P~His-HPr to downstream PTS transporters to allow
uptake of PTS sugars. In this way, the bacterium is able to preferentially utilize a number of
available PTS sugars before turning on the alternative ME pathway.
In order for this form of regulation to be controlling ME expression, it requires a transfer
of the phosphate from P~His-HPr to an ME regulatory protein. Phosphorylation of non-PTS
protein by P~His-HPr is known to occur in a variety of species (for review see (36)) and often
involves a PTS regulatory domain (PRD)- containing protein. Currently, the only non-PTS
protein shown to act as a phosphate acceptor from P~His-HPr in S. pyogenes is the
transcriptional regulator Mga (46). This protein has been characterized as containing several
unique, but related, PRD domains (PRD_Mga) and previous work has shown that P~His-HPr is
able to phosphorylate specific residues within these domains in vitro (46, 47). Although Mga has
been shown to regulate a large number of target genes (3, 4, 47, 48), the ME cluster has not yet
been identified as part of its regulon. Alternatively, there are two additional transcription
regulators in S. pyogenes HSC5 predicted to include a PRD_Mga domain (Paluscio and Caparon,
unpublished), both within the RofA family of regulators (46, 49-51). It remains possible that one
of these proteins may be necessary for ME gene expression. One likely mechanism for this
regulation would be that the phosphate from the P~His-HPr gets transferred to one of the PRD
transcriptional regulators, which then allows this protein to bind to the promoter region of
maeKR and induce its expression. Further evidence to support this hypothesis is the presence of
several putative regulatory elements within the mae promoter region of S. pyogenes (Fig. S1),
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which are absent from the promoters of the other lactic acid bacteria. These sequences may serve
as binding sites for one of the PRD-containing regulatory proteins mentioned above.
This work also demonstrated that the maePE operon is regulated by a pH-dependent
mechanism, whereby acidic pH induces transcription of these genes and neutral pH is inhibitory.
In S. pyogenes, it appears that, in addition, the MaeKR TCS was necessary for this regulation, as
the loss of MaeK prevents the pH-dependent expression of maePE seen in wild type cells.
Interestingly, this work is the first to identify a signal other than malate that is recognized by the
MaeKR regulatory system. Though uncommon, MaeK is not the first transcriptional regulator
identified that is able to respond to multiple extracellular signals. In Escherichia coli, the cad
operon is regulated by CadC, which recognizes both acidic pH and lysine to induce transcription
of the cad genes (52, 53). In Streptococcus mutans the AguR protein, which controls the
expression of the agmatine deiminase system (AgDS), recognizes acidic pH and agmatine (54,
55). An important distinction between CadC, AguR, and MaeK is that former two proteins
require both signals to be present in order to allow for activation and transcription of their target
genes. This work has shown, however, that MaeK functions in the presence of either signal and
does not require both for transcriptional activation. Nonetheless, given that all three proteins
respond to multiple signals, one of which is low pH, they may all share some similar
mechanisms of activation. It is hypothesized that for both CadC and AguR the acidic pH
environment induces a conformational change in the protein, and this change then allows for
binding of the substrate (lysine and agmatine, respectively) (53, 54). Likewise, in the presence of
acidic pH, MaeK may undergo a conformational change that induces activation of the protein.
However, unlike CadC and AguR, the MaeK protein likely has a separate malate sensor domain
that can bind malate in the presence or absence of acidic pH. This mechanism would predict that
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MaeK has two distinct regions required for signal recognition and that either can control the
activity of the protein.
The identification of a pH-dependent response for ME expression is of particular interest
due to the metabolism of the bacterium. S. pyogenes is a member of the lactic acid bacteria, a
group that relies on a mix of homolactic and mixed acid fermentation as a means of generating
energy in the cell (6, 56). Over time, in the presence of rapidly metabolized carbohydrates such
as glucose, high concentrations of organic acid end products will accumulate (Fig. S2) (5, 6, 56,
57). In this way, there is a direct link between carbohydrate availability and pH, with depletion
of glucose leading to a corresponding reduction of the surrounding pH. In this respect, low pH
could function as an early warning signal for changes in carbohydrate availability. Thus, low pH
may function as an inducer of expression for multiple alternative catabolic operons, and is likely
not exclusive to malate catabolism alone. Additionally, the MaeKR TCS may be necessary for
controlling this pH adaptive response for these other catabolic operons.
Taken together, this work demonstrates that under conditions of low glucose or acidic
pH, malic acid catabolic genes are highly expressed. Given that these signals are amongst those
that S. pyogenes encounters at specific points in a soft tissue infection (8-10, 57), the question of
whether this alternative metabolic pathway was important for virulence was of particular interest.
Although all of the ME mutants have similar phenotypes in vitro, a loss of growth on malate, the
mechanism to cause this deficiency is different for each strain. All three attenuated strains are
unable to transport extracellular malate into the cell (either through deletion of the malate
transporter gene or loss of maeP expression in an MaeK- or MaeR- mutant). Alternatively, a
MaeE- mutant is able to transport malate into the cell, but cannot convert this molecule into
pyruvate. This differentiation may, in part, explain the in vivo phenotypes observed.
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In this case, it remains possible that malate may serve a secondary, as yet unknown,
benefit to the bacterial cell independent of increased pyruvate concentrations. Thus, the ability of
a MaeE- mutant to allow uptake of malate may allow for this unused malate to be shuttled into an
alternative pathway, ultimately serving to benefit S. pyogenes during infection. Alternatively,
MaeP-, MaeK-, and MaeR- mutants would be depleted of any internal malate accumulation, and
this loss would ultimately decrease fitness for the cells compared to a WT or a MaeE- mutant. In
this case, it remains possible that malate may serve a secondary, as yet unknown, benefit to the
bacterial cell independent of increased pyruvate concentrations. Thus, the ability of a MaeEmutant to allow uptake of malate may allow for this unused malate to be shuttled into an
alternative pathway, ultimately serving to benefit S. pyogenes during infection. Alternatively,
MaeP-, MaeK-, and MaeR- mutants would be depleted of any internal malate accumulation, and
this loss would ultimately decrease fitness for the cells compared to a WT or a MaeE- mutant.
Another possibility is that the accumulation of intracellular malate in the MaeE- mutant may
cause the mis-regulation of virulence factor expression, leading to enhanced virulence.

In

preliminary studies, we have found that while expression of the SpeB cysteine protease does not
differ between WT and the MaeE- and MaeP- mutants (Fig. S4A), the addition of malate alters
the temporal pattern of SpeB expression in both mutants as compared to WT (Fig. S4B). Since
this alteration in SpeB expression is similar between the two mutants, it cannot explain the
enhanced virulence of the MaeE- mutant. However, it does support the possibility that alterations
to malate metabolism can result in changes in patterns of virulence factor expression. Further
analyses of virulence factor expression will be required in order to determine is specific factors
are specifically mis-regulated in the MaeE- mutant and whether these factor are responsible for
hypervirulence. This work does, however, provide novel insights into the unique regulatory
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mechanisms utilized by S. pyogenes for malate degradation, as well as demonstrate for the first
time the importance of this alternative metabolic pathway on influencing pathogenesis.
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A. Streptococcus pyogenes HSC5
maeP

CATGAAACAACCTCCTTTAGTGATAAGGCTAGTATAAAAGAGAAC 45
SD

mbs1

ATGTCAAAAGCATAGTTTATTTAAGTTGTTTAACTACTTTAATTT 90
mbs3

mbs2

TTTCAAGTTATTTAATTAATTTAAGCTAGCAGGTCATTTCTTATC 135
SD

GTGTTATACTCAATAAAGAGGAGACCTTATG 161
maeK

B. Enterococcus faecalis JH2-2
maeP

CATGCTATTTCCTCCTATAACTTTAATCTATATTCATCATAATGT 45
+1
-10
SD
mbs2
mbs1
cre
AAACGTTTTCTGTAGAGTAGATTATTTAATTAATTTAACTAAAGA 90
mbs3

-10

+1

AAAGTTTTTTAACCAATCTTCCTATGCTATACTTTATTTGAAGAG 135
SD

AAAAGAGGGATGGAATG 151
maeK

C. Lactobacillus casei BL23
maeP

ATGTTTCCTTACCCCCAATCTTTTGTTCTTACAGCATATTGTAA 45
SD
mbs2 -10
cre
mbs1
GCGCTTCATCAGGGGAAGATTATTTAACTTATTAAACCATAAAC 90
mbs3

-10

CCATTTATTTAAGCGATTGTTTTACTATTCACAAGATGGTTTCT 135
SD

CTACTGAACAGGAGTATGATCATG 159
maeK

Figure S1. Schematic representation of ME promoter regions in lactic acid bacteria.
(A) promoter are compared to those of
Predicted functional domains of the
(B) and
(C) [1, 2]. Predicted elements are
shown in grey, while those elements that have been confirmed experimentally are shown
in black. Sites are as follows: (+1), transcription start site; (SD), Shine-Delgarno; (-10),
the -10 promoter region; (mbs), MaeR-binding sites. Degenerate binding sites are
indicated by dotted arrows. Translational start codons are shown in bold font. Predicted cre
sites are highlighted in gray.
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Figure S2. Additional characterization of growth in malate-supplemented media. (A) WT
bacteria were grown in unmodified C medium, C medium plus 0.5% malate, or C medium plus 0.2%
glucose over the course of 8 hrs. Samples were removed every 2 hrs and analyzed for growth (OD600,
left axis) and pH was determined in cell-free supernatants (right axis). Data are presented as means
and standard deviations from 3 biological samples. (B) Lactate and formate concentrations from
cell-free culture supernatants from over-night cultures of WT cells grown in C medium, C medium
supplemented with 0.5% malate, or C medium supplemented with 0.2% glucose were measured (see
Methods). Data are presented as percent of total organic acid concentrations measured and are represented as means and standard deviations from at least 2 biological samples analyzed in triplicate.
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Figure S3. Growth at low pH. WT bacteria were tested for malate utilization by measuring growth over the course of 16 hrs of cultures grown in either unmodified C medium
or C medium plus 0.5% malate, both buffered to pH 6.0. Data are presented as means and
standard deviations from 3 independent experiments.
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A.
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Figure S4. SpeB activity of ME mutants. (A) SpeB activity of WT and ME mutants grown in the
presence or absence of 0.5% malate. Protease activity is apparent as a zone of clearance around
colonies plated on protease indicator plates. (B) Quantification of SpeB activity of WT and ME
mutants grown in the presence of 0.5% malate. Data presented are the means and standard deviations from 2 independent experiments as determined in (8).
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Table S1. Strains used in this study
Descriptionb
Strain
Relevant Genotype Mutated Locia Plasmid
Reference
S. pyogenes
HSC5
wild-type
none
wild-type
Port, et al. (2013)
02310
CKB206
ccpA
none
in-frame deletion of ccpA
Kietzman, et al. (2010)
04180
EP184
maeP
none
in-frame deletion of maeP
This work
04185
EP120
maeE
none
in-frame deletion of maeE
This work
04175
EP121
maeK
none
in-frame deletion of maeK
This work
04170
EP122
maeR
none
in-frame deletion of maeR
This work
04180, 04185 none
EP212
maeP, maeE
in frame deletion of maeP in maeE strain
This work
05585
EP92
ptsI::cat
none
Cam, allelic replacement of ptsI with cat
This work
05590
EP132
ptsHH15A
This work
none
allelic replacement of WT ptsH with ptsHH15A
EP160
maeE
pEP66
Complementation of maeE
This work
EP161
maeE
pABG5
empty vector
This work
restoration of maeK
MaeKR
EP181
none
This work
a. Loci are based on the genome HSC5 (Port et al. 2013) and follow the formate L897_xxxxx, where xxxxx are numbered
b. antibiotics are abbreviated as follows: chloramphenicol (Cam)

Table S2. Primers used in this study
Sequenceab
Name
maeP 5' F (BamHI) GGCGGATCCGAGAGGTTGTGACAACAATCATAGATACC
maeP 5' R
AAATAGCTGTTTGAGGCATTTTCTTGCTTATTGTTT
maeP 3' F
AATGCCTCAAACAGCTATTTTAAGAATTATTTTTAGTTAATCCAA
maeP 3' R (EcoRI) GGCGAATTCCGCAGTACCATCACTGATAACTGC
maeE 5' F (BamHI) GCCGGATCCTTAACATGAACCCAGTGGAAGCAGC
maeE 5' R
ACCTGACGCTAAGGGCAAGTTGACCTAATTGATTTTTCAT
maeE 3' F
ACTTGCCCTTAGCGTCAGGTCGGTAGTCCTTAAATCATAG
maeE 3' R (EcoRI) GCCGAATTCGAAAACTGGAAAGATTGACGCAACAAGAC
maeK 5' F (BamHI) GCCGGATCCTATTTTGCCATGCTTTTGAATGCTC
maeK 5' R
GTTGCCCTCCAACTGGCCCATAAACGTAGTGGTTTTTCAT
maeK 3' F
ATGGGCCAGTACACCTTATGTAGGAGGGCAACATGAACGT
maeK 3' R (EcoRI) GCCGAATTCCTTCGCAAGGAATATGCTGAGCACG
maeR 5' F (BamHI) GCCGGATCCTTCAACATGATCAGAATCATTTAATCAGCC
maeR 5' R
GACGGCCAACGGGATCATCTTCAATGATTAAAACGTTCAT
maeR 3' F
AGATGATCCCGTTGGCCGTCCCTATCGCGTG
maeR 3' R (EcoRI) GCCGAATTCGCCAAGGCCTTACTTCCAGATGAGA
maeE F (EcoRI)
GCCGAATTCTCCAAACCAATAAAAAGAGAGGTATTTCCT
GCCATCGATGCTTCTACTTATTTTGTGATTTAAAGTATAACTTTCTC
maeE R (ClaI)
HPr F (BamHI)
GCGGATCCGCTCTAGCGTTTTGGTGATAGAAGC
HPr R (BamHI)
GCGGATCCCGTCTTGTGCAGCTTGGAGTG
HPr H15A F
TCACATTGTTGCAGAAACAGGTATTGCTGCGCGTCCAGCG
CGCTGGACGCGCAGCAATACCTGTTTCTGCAACAATGTGA
HPr H15A R
maeP RT F
CCGATGTTACTTGGAATGGTTTGTG
maeP RT R
CGACTCCTGTAATGGCACTGTAACC
maeE RT F
TCATATTCCTGTTTTCCATGACGATC
maeE RT R
CTGTCACTTTCGTAGCACCTGCTG
maeK RT F
CGTCAAAACGCAATTATACCCTGTCT
maeK RT R
CCAGCTTTATCTACCACAAATACGGC
maeR RT F
GGCAATGGGATTCAATTTTTGGAG
maeR RT R
CTGTTGGATGCTTTCTTGAAAGCG
a. Engineered restriction sites are underlined
b. Engineered mutation sites are in bold italics

Template
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5
HSC5

Plasmid

Description

pEP78

primers for in-frame deletion of maeP

pEP50

primers for in-frame deletion of maeE

pEP51

primers for in-frame deletion of maeK

pEP52

primers for in-frame deletion of maeR

pEP66

primers for complementation of maeE

pEP56

primers for His15 to Ala point mutation in ptsH

RT primers for maeP
RT primers for maeE
RT primers for maeK
RT primers for maeR

Table S3. Plasmids used in this study
Plasmid (Resistance)a
Description
pGCP213 (Erm)
temperature-sensitive shuttle vector, used for allelic replacement
pCRK (Kan)
temperature-sensitive shuttle vector, used for allelic replacement
pABG5 (Kan, Cam)
shuttle vector, used for ectopic expression

Reference
Nielsen et al. (2012)
Le Breton et al. (2013)
Meehl et al. (2005)

pCRK:: maeP
This work
pEP78 (Kan)
pEP50 (Erm)
pGCP213:: maeE
This work
pEP51 (Erm)
pGCP213:: maeK
This work
pEP52 (Erm)
pGCP213:: maeR
This work
pGCP793 (Erm, Cam)
pGCP213:: ptsI::cat
Port et al. (2014)
pEP56 (Erm)
pGCP213::ptsHH15A
This work
pEP66 (Kan, Cam)
pABG5:: maeE (for MaeE complementation)
This work
pCRK::maeK (for MaeK restoration)
pEP74 (Kan)
This work
a. Antibiotics are abbreviated as follows: kanamycin (Kan), chloramphenicol (Cam), erythromycin (Erm)
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MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. The Escherichia coli strain TOP10
(Invitrogen) was used for cloning using standard molecular biology techniques. The
Streptococcus pyogenes strain HSC5 (23) and mutant derivatives were utilized in this study.
Strains were grown in Todd Hewitt broth (THYB) with 0.2% yeast extract (Difco) or C medium
(24). C medium was adjusted to pH 7.5 as described previously (24). Routine growth conditions
utilized sealed culture tubes incubated at 37°C under static conditions. Streptococcal strains
grown on solid medium containing 1.4% Bacto agar (Difco) were cultured in a sealed jar with a
commercial gas generator (GasPak catalogue no. 70304, BBL). For experiments utilizing malate
supplementation, filter sterilized 5% (w/v) stock solution buffered to pH 7.0 with NaOH (Sigma)
was used to add malate (Sigma) to a final concentration of 0.5% to the media. For experiments
utilizing glucose or maltose supplementation, filter sterilized 20% (w/v) stock solution was used
to add glucose or maltose (Sigma) to a final concentration of 0.2% to the media. For experiments
utilizing buffered media, 1M stock solutions of HEPES (pH 7.5) or MES (pH 6.0) (both obtained
from Sigma) were added to a final concentration of 0.1M to the media. All media used were
sterilized in an autoclave prior to supplementation. When appropriate, antibiotics were added at
the following concentrations: erythromycin 1 mg/mL, kanamycin 250 mg/mL, chloramphenicol
3 mg/ml.

Construction of mutants. All references to genomic loci are based on the genome of HSC5
(23). In-frame deletion mutations in the genes encoding MaeP (L897_04180), MaeE
(L897_04185), MaeR (L897_04170), and MaeK (L897_04175), as well as the modified allele
for HPr (L897_05590) (Table S1) were generated using allelic replacement and the PCR primers
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listed in Table S2. The deletion alleles were transferred to the HSC5 chromosome using the
allelic replacement vector pGCP213 (25) as described (26) and listed in Table S3. Each deletion
allele was obtained through overlap extension PCR (27) using the primers listed in Table S2. All
molecular constructs and chromosomal structures of all mutants were verified using PCR and
DNA sequencing (Genewiz, South Plainfield, NJ) using oligonucleotide primers (IDT,
Coralville, IA) of the appropriate sequences.

Complementation of ME mutants. To complement the maeE in-frame deletions, DNA
fragments containing maeE from HSC5 in the absence of its promoter was amplified using the
primers listed in Table 2 and inserted under control of the rofA promoter in pABG5 as previously
described (28). The resulting plasmid, pEP66, was then used for ectopic expression of MaeE,
(Table S3). For complementation of the maeK in-frame deletion, a reversion strategy was used to
restore the wild-type locus in the MaeK- mutant background. A DNA fragment containing the
maeK open reading frame and flanking regions was amplified from HSC5 using primers listed in
Table S2 and inserted into the plasmid pCRK (29). The resulting plasmid, pEP74, was then used
to create the strain MaeKR as described previously (30) (Table S1).

Metabolic assays. Malate, lactate, and formate concentrations were measured using
commercially available kits (Sigma). Briefly, cultures of each individual strain tested were
grown overnight in C medium with the appropriate supplement added (see text). Cultures were
then subjected to centrifugation, filtered through 0.22 μm filters (Millipore), and then assessed
per manufacturer’s protocol. Data shown are the means and standard deviation from duplicate
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determination of three separate biological samples prepared from at least 2 independent
experiments.

Isolation of RNA and transcript analysis. Transcript abundance of selected genes was
analyzed as previously described (31). Briefly, overnight cultures were diluted 1:25 into fresh C
medium with the appropriate supplement added (see text) and harvested at mid-log phase (OD600
0.2). Total RNA was isolated using Qiagen RNeasy Mini kit per the manufacturer’s protocol.
RNA was subjected to reverse transcription (RT) using iScript (Bio-Rad) per manufacturer’s
protocol. RT-PCR analysis of cDNA samples were performed using iQ SYBR Green Supermix
(Bio-Rad) and the primers listed in Table S2. Relative transcript abundance was determined
using the ΔΔCt method using recA transcript as a standard and are presented in comparison to
unmodified C media or in comparison to wild type. The data shown are the means and the
standard deviation from triplicate determinations of at least two separate biological samples
prepared from at least two independent experiments.

Infection of mice. As previously described (32, 33), 5-to-6-week-old female SKH1 hairless mice
(Charles River Labs) were injected subcutaneously with approximately 107 CFU of S. pyogenes
of the strains indicated in the text. Following infection, the resulting ulcers formed were
documented over a period of several days by digital photography and lesion areas measured as
previously described (32). Data presented is pooled from at least two independent experiments
with at least 10 mice per experimental group.
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Growth rate calculations. Indicated bacterial strains were back-diluted 1:50 into 1 mL of fresh
C medium (unmodified or altered as indicated in text) and their growth monitored at 37°C using
a Tecan Infinite M200 Pro plate reader. During growth the plate was shaken every 10 minutes
for 30s, followed by a 5s wait period and measurement of the OD600. Data was normalized
relative to uninoculated media and growth rates calculated as described previously (34). Growth
rates are reported as doubling time (t1/2) and were determined from a series of 7 time points
collected over a 60 minute period that defines the peak rate of growth, which typically occurred
prior to the culture reaching 15-30% of max OD600. Growth yields were calculated from the
maximum OD600 reached by the culture and are expressed as a percentage relative to the wild
type strain under identical conditions. The average doubling time and percent growth yield was
calculated from each replicate from at least three independent experiments.

Statistical analyses. Differences between mean values obtained for wild type and mutant strains
in in vitro assays were tested for significance using the Student’s t-test. For infection of mice,
differences in lesion area between wild type and individual mutants were tested for significance
using the Mann-Whitney U test. Computation of test statistics utilized Instat (version 3.1) and
Prism (version 6.0) from Graphpad Software (San Diego, CA). For all tests, the null hypothesis
was rejected for P < 0.05.
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Chapter III
RocA is Required for Growth-Phase Expression of
Virulence Factors SPN and SLO in Streptococcus
pyogenes
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SUMMARY
The interaction between the NAD+ glycohydrolase SPN and the cholesterol dependent
cytolysin SLO allows for delivery of SPN directly into host cells by a process known as
cytolysin-mediated translocation (CMT). It has also been shown that both proteins play a role in
cytotoxicity, as loss of either protein has reduced virulence in cultured epithelial cells and in vivo
in a mouse model of soft tissue infection. Taken together, these studies demonstrate that both
SPN and SLO play an important role in pathogenesis of S. pyogenes. And although these
secreted proteins have been shown to be involved in virulence of S. pyogenes, little information
is known about how the bacterium regulates their expression. Analysis of expression patterns for
these genes demonstrated that both are growth-phase regulated, with peak expression at
exponential phase. Additionally, this temporal expression pattern is controlled by environmental
pH, where acidic pH has a repressive effect on expression of both genes. Through a transposon
mutagenesis screen a novel regulator of the spn operon, RocA, a predicted histidine kinase, was
identified. An analysis of the RocA protein revealed that, although it does function as a
transcriptional repressor of the spn operon, it is not a histidine kinase. Finally, RocA, along with
the two-component system CovRS, is shown to be essential for the pH regulation of the spn
operon. Taken together, this work sheds light on a regulatory mechanism utilized by S. pyogenes
during adaptation to acid stress.
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INTRODUCTION
An important factor in the colonization of host tissue by a pathogen is the ability to
monitor changes in their surrounding environment and adapt as needed for survival. This
adaptation is often seen at the level of transcription, resulting in careful spatial and temporal
expression patterns of a number of proteins, including virulence factors. Identifications of
conditions that control gene expression in vitro is, therefore, a useful tool for understanding the
potential regulatory cues sensed by the bacteria during an infection in vivo.
The Gram-positive bacterium Streptococcus pyogenes is an incredibly versatile pathogen,
capable of colonizing numerous sites within the human host and causing a variety of clinical
diseases. These diseases range from mild, self-limiting infections such as impetigo and
pharyngitis, to invasive and systemic diseases including toxic shock and necrotizing fasciitis (13). The ability of S. pyogenes to successfully infect multiple niches in the human body is the
result of careful monitoring of variations in environmental stimuli, which, in turn, lead to global
transcriptional changes in the bacterium (4-6). The regulatory cues that can lead to this
transcriptional remodeling include temperature, pH, osmolarity, and nutrient availability, among
others (5-8)
As a lactic acid bacterium (LAB), S. pyogenes is solely dependent on a simple
fermentative metabolism to generate energy in the cell (9, 10). A by-product of this metabolism
is the production of several organic acid end products that, over the course of growth,
accumulate in high concentrations in the surrounding area (9, 10). This autoacidification process
is significant for several reasons. First, it has been established that pH is a signal used by the
bacterium to induce global transcriptional changes (7, 11, 12). Second, transcriptome studies
have shown that the local tissue environment during later stages of infection is both low in
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glucose and low in pH (7). Therefore, understanding the regulatory mechanisms utilized by S.
pyogenes in response to variations in environmental pH will provide insight into important
adaptive strategies that the bacterium must use in vivo in infected tissue.
S. pyogenes is known to produce a large number of secreted virulence factors that can
affect host cellular functions in numerous ways (1-3, 13-17). One important secreted factor is the
NAD+ glycohydrolase, SPN. Upon delivery into the host cell cytosol, SPN is able to cleave βNAD+ into nicotinamide and adenosine diphosphoribose (ADPr) (14, 18, 19). The process by
which SPN is able to gain access to the host cytosol is a complex process known as cytolysinmediated translocation (CMT) (20-22). CMT also requires the cholesterol dependent cytolysin
Streptolysin O (SLO) for the direct translocation of SPN across the host cell membrane (20-22).
It has also been established that both proteins play a role in pathogenesis, as loss of either protein
has reduced virulence in cultured epithelial cells and in vivo in a mouse model of soft tissue
infection (20, 23, 24). While a significant amount of work has been done in understanding the
complex process of CMT, as well characterizing SPN’s effects on the host cell (14, 18, 20-22,
25), little is known about how the bacterium regulates the expression of these important toxins.
While S. pyogenes lacks alternative sigma factors, it encodes a number of two-component
systems (TCS) and stand-alone response regulators, many of which are influenced by both
growth phase and environmental conditions (5, 6, 26-32). One of the most well characterized
transcriptional regulators in GAS is the two-component system (TCS) CovRS. This system
exerts its effect during late exponential and stationary growth, functioning mostly as a repressor
of a number of surface-adhered and secreted virulence factors in response to multiple
environmental stimuli including Mg2+, temperature, pH, and the cathelicidin LL-37 (27, 33-38).

	
  
	
  

92	
  

CovRS is one of the most well studied TCSs in S. pyogenes and is known to control up to 15% of
the total genes in this bacterium, including spn and slo (33, 35, 38).
spn is the first gene in a 3-gene operon that includes ifs (immunity factor for SPN) and
slo (19, 25, 39). While both SPN and SLO are secreted, IFS is a bacterial cytosolic protein that
binds to SPN’s active site to block its enzymatic activity within the bacterial cell (39). From few
global transcription studies it has been established that expression of the spn/slo operon is
associated with exponential phase of growth (4, 30), indicating that it is growth-phase regulated,
however, the signal controlling this expression remains unclear. Additionally, while it is known
that spn and slo are repressed by CovRS, it is not known if this is through direct or indirect
regulation. Moreover, it remains unknown if any additional transcriptional regulators control the
spn operon.
In this study we examined the regulatory mechanism controlling the growth phase
regulation of the spn/slo operon. The analysis revealed that expression of the spn operon is
controlled by pH and that this regulation requires both the CovRS system as well as a standalone transcriptional regulator, RocA.
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RESULTS
Expression of spn and slo is controlled by pH. As a lactic acid bacterium, S. pyogenes growth
in broth culture can have a significant effect on the pH of the medium. Growth in a glucose-rich
medium such as THY results in a substantial reduction in environmental pH from a starting point
of 7.4 to a low of approximately 5.4 (Fig. 1A).

Figure 1. Growth-phase expression of spn and slo. (A) WT S. pyogenes was grown in THY
medium over the course of 8 hours. Samples were removed at various time points and analyzed
for growth (OD 600, left axis) and pH of cell-free supernatants were measured (right axis). (B)
Transcript abundance of spn and slo (left axis) and pH of cell-free supernatants (right axis)
were measured at specified stages of growth (OD600, x-axis). Results are presented as mean and
standard deviations from at least 2 biological samples analyzed in triplicate.

Transcriptional expression of the spn/slo operon is associated with the exponential phase
of growth (4, 30), when culture pH is still near neutral (Fig. 1B). To provide more cumulative
data on the pattern of transcriptional expression of this operon, WT cells were inoculated into
fresh THY medium and samples were collected at seven distinct time points throughout the
growth cycle and transcript abundance of spn and slo were measured (Fig. 1B). Both spn and slo
had similar patterns of expression, with induction beginning during early exponential phase
(OD600 of 0.2), peaking at mid-exponential phase (OD600 of 0.5), and then rapidly turned off as
cells entered late exponential/stationary phase (OD600 of 1.0). This late phase in the growth cycle
correlated with the culture pH dropping to an acidic level of approximately 6.0-6.5 (Fig. 1B).
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These data led to the hypothesis that transcription of the spn operon is regulated by
environmental pH, where acidic pH is a repressive signal on transcription of these genes.

Figure 2. Expression of spn and slo is regulated by pH. (A and B) WT S. pyogenes was grown
in THY buffered to specified pH and SPN and SLO protein was measured from cell-free
supernatants by Western blot (A) or NADase activity (B). (C and D) Transcript abundance of spn
and slo was measured from WT cells grown in THY buffered to pH 6.0 (C) or 7.5 (D). For analysis
total RNA was isolated from cultures at exponential phase (C) or stationary phase (D).

To test this, WT cells were grown in THY medium buffered to a range of pHs from 7.5 to
6.0. Cell-free supernatants from these overnight cultures were collected and analyzed by Western
blot for expression of both SPN and SLO protein levels (Fig. 2A). Supernatants from cultures
buffered to pH 7.5 had substantially more SPN and SLO than samples from cultures grown in
unmodified THY. Conversely, growth in THY medium buffered to pH 6.5 or 6.0 repress protein
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expression to undetectable levels. As a control to show that general protein secretion is not
affected, supernatants were also tested for levels of SpeB protein, which has been shown to be
positively regulated by low pH (Fig. 2A) (7). As a second measure of SPN production, cell-free
supernatants from cultures grown in unmodified THY or THY buffered to neutral (7.5) or acidic
(6.0) pH were collected and analyzed for β-NAD+ glycohydrolase (NADase) activity (Fig. 2B).
Results of this analysis show that, compared to unmodified THY, neutral buffered media
enhanced NADase activity 2- to 3-fold, while acidic buffered media reduced NADase activity 2fold. As a negative control, overnight supernatants of strain HSC5 (which produces an NADase
negative version of SPN) (18). All together, this data demonstrates that low pH is a repressive
signal for SPN and SLO expression and that production of these proteins can be enhanced by
buffering the medium to a neutral pH.
To determine whether the pH regulation of SPN and SLO was occurring at a
transcriptional or post-transcriptional level, WT cells were grown in buffered THY medium and
samples were collected at a specific stage of growth and transcript abundance of the spn and slo
genes were measured (Fig. 2 C and D). WT cells were grown in either acidic buffered THY (pH
6.0) to mid-exponential phase (OD600 of 0.5) or in neutral buffered THY to late
exponential/stationary phase (OD600 of 1.2). Results of this analysis show that growth in acidic
media represses transcription of both spn and slo at exponential phase approximately 4-fold (log2
value) compared to cells grown in unmodified THY (Fig. 2C). Additionally, late
exponential/stationary phase cells grown in neutral buffered media had 4- to 6-fold (log2 value)
increased transcript abundance compared to cells grown in unmodified THY (Fig. 2D). Taken
together, these results demonstrate that pH is an environmental signal controlling the growth
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phase expression of the virulence genes spn and slo, where low pH is a repressive signal for
transcription of this operon.

Figure 3. Deletion of RocA uncouples spn and slo from pH regulation. (A) Schematic of the
genomic region containing the rocA gene (L897_06555) in S. pyogenes. Green arrows indicate
location of transposon insertion sites. (B and C) The S. pyogenes RocA - mutant was grown in
THY buffered to specified pH and SPN and SLO protein was measured from cell-free
supernatants by Western blot (C) or NADase activity (D).

Deletion of RocA uncouples spn and slo from pH regulation. A random mutagenesis screen
was performed in order to identify potential regulators involved in controlling the expression of
the spn/slo operon in response to low pH. We screened approximately 2000 transposon mutants
for production of SPN, measured by NADase activity of culture supernatants, after growth in
THY pH 6.0. Within the mutant library, two independently derived transposon mutants were
discovered to have high NADase activity in acidic THY. These mutants both had a transposon
disruption in a gene (L897_06555) annotated in the HSC5 genome as a putative histidine kinase
(Fig. 3A) (40). A BLAST search for related genes in S. pyogenes lead to the identification of the
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unknown kinase as the gene rocA, a highly conserved gene present in all sequenced strains of S
pyogenes. RocA was first identified as a transcriptional regulator and was shown to act as a
positive regulator for the covRS operon in JRS4 (40). Examination of the genomic region around
rocA is that it appears to be a stand-alone histidine kinase (Fig. 3A), which is unusual as these
proteins are usually part of a two-component system where both genes are encoded in a single
operon (41). However, this is not the case for this gene of interest.
To verify that the rocA disruption is responsible for the SPN over-expression phenotype,
a strain was made with an in-frame deletion of rocA in a WT background. This strain, RocA-,
was then tested for altered expression patterns for both SPN and SLO. RocA- cells were grown
overnight in THY unmodified or buffered to pH 7.5, 6.5, or 6.0 and supernatants were collected
for Western blot analysis. The results show that, under all conditions tested, RocA- causes
overproduction of both SPN and SLO protein (Fig. 3B). As a second measure of SPN expression,
WT and RocA- strains were grown overnight in THY, THY pH 7.5, or THY pH 6.0 and
supernatants were collected and measured for NADase activity. The results demonstrated that the
RocA- strain had consistently high NADase activity compared to WT under all pH conditions
(Fig. 3C). Thus, loss of the RocA protein uncouples SPN and SLO from pH regulation. To
restore pH repression of SPN and SLO the rocA gene was expressed ectopically on a plasmid
under a constitutive promoter. This plasmid (pRocA) was then used to transform
both WT and a RocA- mutant and NADase activity of supernatants from overnight cultures
grown in unmodified THY medium was measured. Surprisingly, over-expression of RocA
repressed SPN production by 80% in unmodified media (Fig. 4A). Thus, over-expression of
RocA can repress SPN in the absence of any pH signal.
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RocA is a transcriptional repressor
of spn and slo. As a putative histidine
kinase, RocA would be predicted to be
part of a TCS and, therefore, is likely a
transcriptional regulator. To test this,
total RNA from WT and RocA- strains
grown in unmodified THY was
collected and transcript abundance of
spn and slo were measured by
quantitative RT-PCR (Fig. 4B). The
results show that loss of RocA causes
an increase in transcript of both genes
approximately 10-fold compared to
WT. Additionally, when RocA was
then ectopically expressed on a plasmid
(pRocA) in either a WT or a RocAbackground, transcript levels were
dramatically reduced nearly 10-fold
compared to the non-complemented
strains (Fig. 4B). Additionally, it is

Figure 4. RocA is a transcriptional repressor of spn
and slo. (A) NADase activity of cell-free supernatants
from WT and RocA- cultures containing indicated
plasmid was measured. (EV, empty vector) (B) Total
RNA from exponential phase cultures slo of WT and
RocA- strains containing indicated plasmid was
isolated and transcript abundance of spn and was
measured. Data presented is means and standard
deviation from 3 biological replicates measured in
triplicate.

important to note that this experiment was performed with cells grown in unmodified THY,
indicating that overexpression of RocA alone is sufficient to repress transcription of spn and slo
and does not require a strong acidic pH signal to induce this repression. Taken together, this data
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shows that RocA is a transcriptional repressor of spn and slo and can function independently of a
pH signal.

RocA is not a histidine kinase. Given how little this protein has been studied at this point, we
sought to further characterize its functional activity. Previously, it has been hypothesized that
RocA is a histidine kinase (42). Using structural prediction software (43), we obtained a putative
structure of the cytoplasmic domain of the RocA protein. Histidine kinases (HK) are
characterized as having three domains, the extracellular sensor domain (which vary among the
different proteins), a transmembrane domain, and a cytosolic enzymatic domain. These last two
domains are highly conserved among HKs (44). An examination of the cytoplasmic domain of
RocA revealed that there was four histidine residues scattered throughout this domain (H247,
H315, H387, H437) (Fig. 5A). To identify the key histidine residue necessary for RocA’s
function, single point mutations were made by directed mutagenesis using the pRocA plasmid,
converting His to Ala independently at all four positions. These new constructs (pRocAH247A,
pRocAH315A, pRocAH387A, pRocAH437A) were transformed into the RocA- mutant and tested for
protein expression and NADase activity (Fig. 5 B and C). The results show that all four pRocA
mutant were able to repress SPN and SLO expression to similar levels as the WT pRocA,
indicating that all four histidine mutants are dispensable for RocA regulatory function.
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SPN

SpeB

Figure 5. RocA is not a functional histidine kinase. (A) Structural prediction of RocA’s
cytoplasmic domain with individual histidine residues highlighted in red. (B and C). pRocA mutant
constructs were tested for regulation of SPN by NADase activity (B) and Western blot (C).

RocA repression of SPN and SLO requires CovRS. Given that RocA was initially identified
as a regulator of the covRS operon (40), and that the CovRS TCS is a known regulator of the
spn/slo operon (33, 35, 38), it was of interest to investigate if RocA-mediated regulation of spn
and slo involved CovRS. To test this, in-frame deletion mutants of covR or covS were made
individually in a WT background and these mutants were tested for altered SPN production by
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measuring NADase activity of culture supernatants (Fig. 6). Results showed that deletion of
either gene lead to significantly higher levels of NADase activity than WT, indicating that both
CovR and CovS are required for repression of SPN. This finding was in agreement with previous
reports of CovRS regulation of the spn/slo operon and appeared identical to a RocA- mutant (33,
35, 38). Lastly, to evaluate the contribution of either protein in the RocA regulatory pathway, the
plasmid pRocA was transformed into both CovR- and CovS- and these strains were tested for
SPN production. NADase activity of overnight supernatants from cultures grown in unmodified
THY broth from strains RocA-, CovR-, CovS-, plus their pRocA complemented strains. The
results show that over-expression of RocA on pRocA can only complement the RocA- mutant,
but neither of the Cov deletion mutants (Fig. 6). Thus, all three components are required for
repression of the spn/slo operon.

Figure 6. RocA repression of SPN requires CovRS NADase activity of cell-free
supernatants from WT and mutant and complemented strains was measured.
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DISCUSSION
In this study we have shown that the virulence factors SPN and SLO, which are cotranscribed together with the protein IFS in a single operon, are expressed in a growth-phase
pattern of expression, with their peak transcript abundance occurring during exponential phase.
In addition, we have shown that this pattern of regulation is controlled by environmental pH,
where exposure to acidic conditions can repress transcription of this operon and, conversely,
maintenance of a neutral pH can extend transcription through to stationary phase. Furthermore,
we have identified the transcriptional regulator RocA, in addition to the global regulatory TCS
CovRS, as being required for this pH-mediated response. Finally, we have shown that while
RocA is, in fact, a transcriptional regulatory protein, it is likely not a functional histidine kinase
as previously reported. Taken together, these data shed light on the specific growth-phase
regulation of several important virulence factors and further characterizes the contribution of
RocA in S. pyogenes pathogenesis.
Growth-phase expression of virulence factors is a common regulatory strategy used by
multiple pathogenic bacterial species (10, 31, 45). Often times this growth-phase regulation is
linked to metabolism. For example, in S. pyogenes, the catabolite control protein CcpA regulates
a number of virulence factors including the cysteine protease SpeB and the lactate oxidase gene
lctO in response to carbohydrate availability (46). The transcriptional regulator CodY, which
recognizes branched chain amino acids, is responsible for the growth-phase regulation of the
virulence factors pel and sagA (6). We can now add the genes spn and slo to this group. As a
lactic acid bacterium, S. pyogenes ferments glucose, leading to the formation of multiple organic
acids which, when secreted into the environment, cause a significant drop in pH (9, 10, 31, 45,
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47). Thus, as glucose is consumed, there is a corollary drop in environmental pH. In this way, pH
is an indirect metabolic signal for the bacterial cell.
This work also provides new information on the role of RocA and its involvement with
the CovRS TCS. Although RocA is a highly conserved protein present in all sequenced S.
pyogenes strains, few studies have been done to characterize this protein and it’s role in virulence
regulation and pathogenesis. Previous studies have identified RocA as a regulator of hasA, which
is necessary for capsule synthesis (40, 42), although this is attributed to the fact that RocA is a
regulator of CovR, which is known to repress capsule synthesis genes (27). There is, however,
data that suggests that RocA’s role in transcriptional regulation extends beyond interactions with
CovRS. A proteomics study to identify regulatory targets of RocA identified approximately 30
proteins whose expression were significantly altered in a RocA null mutant compared to WT
(42). Of these 30 targets, only one third of them were determined to be part of the CovRS
regulon. In addition, the majority of these RocA targets, most of which are repressed by the
protein, are involved in metabolism (42). Thus, RocA’s main contribution to the cell may be as a
key metabolic regulator. As previously mentioned, there are a few well-characterized metabolic
regulators in S. pyogenes known to respond to various nutritional cues such as glucose,
carbohydrates, and amino acid starvation (5, 6, 28, 46). An important next step in the study of
RocA would be to determine what conditions or signals it responds to. The work presented here
suggests that pH may be one of those signals, but, like CovRS (34, 36, 38), RocA may recognize
multiple environmental cues.
In addition to identifying the conditions that trigger RocA activation, there is also the
question of how RocA is functioning as a transcriptional regulator. The work presented here
demonstrates that RocA is not a functional histidine kinase, as all histidine residues within the
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cytoplasmic domain of the protein are dispensable for function. This conclusion is further
supported by previous findings that the RocA protein sequence lacks several key residues
necessary for function in other known histidine kinases (40). Additionally, analysis of the
sequence of the predicted ATPase domain of the protein also revealed mutations to key residues
necessary for enzymatic activity (E. Paluscio and M. Caparon, unpublished). Taken together, this
information suggests that RocA may not possess any enzymatic activity. Additionally, no DNA
binding domains have been identified in RocA, yet there is strong evidence from this work and
other that indicate this protein is involved in transcriptional regulation of multiple target genes
(40, 42).
Given that RocA maintains strong homology to other bacterial histidine kinases, but
lacks the specific residues necessary for phosphorylation, a possible hypothesis is that RocA is a
functional pseudokinase. Pseudokinases can be described as proteins that are classified as part of
a specific enzyme group based on sequence or structural homology, but lack any enzymatic
activity (48). Pseudokinases, which are found in all domains of life, are thought to function in
signaling pathways in several specific ways, including as modulators of kinase and phosphatase
activity (49-52). In the case of RocA and regulation of the spn operon, we hypothesize that this
protein is affecting the phosphorylation state of CovR through modulation of CovS’s enzymatic
activity.
CovS has been shown to maintain both kinase and phosphatase activity (53), thus altering
the phosphorylation state of CovR. Additionally, it has been suggested that CovR’s
phosphorylation state determines its regulatory function, including which target promoters it can
bind to and whether it functions to enhance or repress transcription of its target genes (27, 53,
54). It is possible that for regulation of spn, and possibly additional genes, the interaction
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between RocA and the CovRS system is necessary for sufficient transcriptional repression. The
concept of a TCS requiring auxiliary proteins for signal transduction is a common mechanism
among both Gram-positive and Gram-negative species and has been associated with a variety of
cellular processes from cell division to virulence factor regulation (50, 51, 55-57). The precise
mechanism by which this is occurring to regulate the growth phase expression of the spn/slo
operon remains unclear. However, the work presented here has established that this regulation is
controlled by environmental pH and provides new insights into virulence gene regulation in S.
pyogenes.
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MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. The Escherichia coli strain TOP10
(Invitrogen) was used for cloning using standard molecular biology techniques. The
Streptococcus pyogenes strain JOY3 (18), which is an NADase positive version of the strain
HSC5 (58), and mutant derivatives were utilized in this study. Strains were grown in Todd
Hewitt broth (THYB) with 0.2% yeast extract (Difco). Routine growth conditions utilized sealed
culture tubes incubated at 37°C under static conditions. Streptococcal strains grown on solid
medium containing 1.4% Bacto agar (Difco) were cultured in a sealed jar with a commercial gas
generator (GasPak catalogue no. 70304, BBL). For experiments utilizing buffered media, 1M
stock solutions of HEPES (pH 7.5) or MES (pH 6.0) (Sigma) were added to a final concentration
of 0.1M to the media. All media used were sterilized in an autoclave prior to supplementation.
When appropriate, antibiotics were added at the following concentrations: erythromycin 1
mg/mL, kanamycin 250 mg/mL, spectinomycin 100mg/mL.

Mutagenesis strategy. Transposon mutagenesis utilized a modified version of Tn4001
containing a spectinomycin resistance cassette (59). Construction of a transposon mutant library
was conducted as described previously (59). For mutants of interest, the transposon insertion site
was mapped by arbitrary PCR as described (60). Briefly, DNA flanking the transposon insertion
site is enriched through two rounds of amplification using primers specific to the 5’ end of the
transposon and nonspecific primers that can anneal to random sites within the bacterial
chromosome. The first round of PCR was performed using primers ARB1 (5’GCCGACCGCTGGACTGTACG	
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NNNNNNNNNNGTAGC) and OUT3 ((5’- GCGTGCCTACACGTGTCG). The second round
of PCR utilized 5μL of the first-round product as the template and PCR primers ARB2 (5’GCCGACCGCTGGACTGTACG) and OUT1 (5’-GTCCTCCTGGGTATGTTTTT). Second round PCR products were purified and sequenced using primer OUT1.

Directed mutagenesis and complementation. All references to genomic loci are based on the
genome of HSC5 (58). In-frame deletion mutations in the genes encoding RocA (L897_06555),
CovR (L897_01565), and CovS (L897_01570) (Table 1) were generated using allelic
replacement and the PCR primers listed in Table 2. The deletion alleles were transferred to the
HSC5 chromosome using the allelic replacement vector pGCP213 (61) as described (62) and
listed in Table 3. Each deletion allele was obtained through overlap extension PCR (63) using the
primers listed in Table 2. All molecular constructs and chromosomal structures of all mutants
were verified using PCR and DNA sequencing (Genewiz, South Plainfield, NJ) using
oligonucleotide primers (IDT, Coralville, IA) of the appropriate sequences. To complement the
rocA in-frame deletions, DNA fragments containing rocA from HSC5 in the absence of its
promoter and including an HA tag at the C-terminal end of the protein was amplified using the
primers listed in Table 2 and inserted under control of the rofA promoter in pABG5 as previously
described (39). The resulting plasmid, pEP85, was then used for ectopic expression of RocA-HA
(Table 3). The four RocA mutants (H247A, H315A, H387A, H437A) were made from the WT
rocA sequence in pEP85 using the Quikchange XL II mutagenesis kit (Agilent Technologies).
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Analysis of protein expression. SPN production was measured by a fluorometric assay
measuring β-NAD+ glycohydrolase activity of cell-free supernatants as described (20). Specific
activity of each strain is reported relative to wild type as described (19). Expression of SPN and
SLO protein was measured from cell-free supernatants as described (22). For all experiments,
samples were normalized to OD600 of overnight cultures.

Isolation of RNA and transcript analysis. Transcript abundance of selected genes was
analyzed as previously described (64). Briefly, overnight cultures were diluted 1:25 into fresh
THY medium with the appropriate supplement added (see text) and harvested at the OD600
indicated in the text. Total RNA was isolated using Qiagen RNeasy Mini kit per the
manufacturer’s protocol. RNA was subjected to reverse-transcription (RT) using iScript (BioRad) per manufacturer’s protocol. RT-PCR analysis of cDNA samples were performed using iQ
SYBR Green Supermix (Bio-Rad) and the primers listed previously (7). Relative transcript
abundance was determined using the ΔΔCt method using recA transcript as a standard and are
presented in comparison to unmodified THY media or in comparison to wild type. The data
shown are the means and the standard deviation from triplicate determinations of at least two
separate biological samples prepared from at least two independent experiments.
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Table 1. Strains used in this study
Strain
Relevant Genotype Mutated Locia
S. pyogenes
JOY3
SPNJ4
00945
HSC5
EP154
∆rocA
06555
EP155
∆covS
01570
EP156
∆covR
01565
EP177
SPNJ4
00945
EP180
∆rocA
06555
EP178
∆covS
01570
EP179
∆covR
01565
EP181
SPNJ4
00945
EP182
∆rocA
06555
EP183
∆covS
01570
EP184
∆covR
01565
EP185
∆rocA
06555
EP186
∆rocA
06555
EP187
∆rocA
06555
EP188
∆rocA
06555

Plasmid

Descriptionb

Reference

none
none
none
none
none
pABG5
pABG5
pABG5
pABG5
pEP85
pEP85
pEP85
pEP85
pEP86
pEP87
pEP88
pEP89

wild-type
NAD+ glycohydrolase negative
in-frame deletion of rocA
in-frame deletion of covS
in-frame deletion of covR

Chandresakaran, et al. (2013)
Port, et al. (2013)
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work

a. Loci are based on the genome HSC5 (Port et al. 2013) and follow the formate L897_xxxxx, where xxxxx are numbered
b. antibiotics are abbreviated as follows: chloramphenicol (Cam)
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Chapter IV
Alterations of CcpA Activation has Significant Effects
on the Outcome of a Streptococcus pyogenes Infection
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SUMMARY
Streptococcus pyogenes can infect a number of different tissue types within the human
host. Successful adaptation to these varying environments is, in part, due to the bacterium’s
ability to sense changes in environmental signals and rapidly alter its gene expression profile in
response to these changes. Carbon catabolite repression (CCR) allows the bacteria to metabolize
preferable carbon sources in the environment, usually through transcriptional repression of genes
in the processing of alternative, and less favorable, carbon sources. The key transcriptional
regulator of CCR in S. pyogenes is CcpA. This protein has been shown to be a global regulator of
gene expression, affecting transcription of genes involved in both carbon metabolism as well as a
number of known virulence factors. The majority of the identified CcpA-regulated genes are
upregulated in the absence of the protein, demonstrating that the main role of CcpA is in
repression of target genes. A great deal of work has been done to characterize the role of CcpA
in S. pyogenes pathogenesis, however, all of these previous studies utilize CcpA null mutants.
But, given the fact that CcpA acts mostly as a repressor of target genes, these previous studies
are unable to demonstrate the significance of CcpA function on metabolism and pathogenesis. To
provide a more complete analysis of CcpA function, we have designed a constitutively active
CcpA protein, CcpAT307Y. Both a CcpA- and CcpAT307Y mutants were then tested for altered
virulence in a soft tissue infection and in a vaginal mucosal colonization model. Both CcpA
mutants displayed altered virulence phenotypes in both models of infection. Further
characterization of the effects of these mutants on pathogenesis may lead to new insights into the
role of CcpA regulation in S. pyogenes.
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INTRODUCTION
Carbon catabolite repression (CCR) is the mechanism by which bacteria preferentially
metabolize one carbon source over another from their environment, primarily through
transcriptional repression of genes necessary for processing alternative, and less favorable,
carbon sources. The key transcriptional regulator of CCR in low G+C Gram-positive bacteria is
the catabolite control protein A (CcpA) (1-4). In addition to controlling metabolic genes, CcpA
has been identified as a regulator of several virulence factors in a number of pathogenic bacterial
species (2, 5-8). This indicates that nutrient availability is linked to virulence factor production
and pathogenesis.
In the bacterium Streptococcus pyogenes, CcpA has been shown to be a global regulator of
gene expression, affecting transcription of approximately 20% of the total genome. S. pyogenes
is known to cause a wide variety of infections at numerous different tissue sites within the human
host (9-13). The diseases caused by S. pyogenes range from mild and self-limiting infections
such as impetigo and pharyngitis, to systemic and life threatening diseases such as cellulitis and
necrotizing fasciitis, as well as serious postinfection sequelae such as rheumatic fever and
glomerulonephritis (9, 10, 12, 14). The ability of S. pyogenes to infect a number of different
tissue types within the human host is, in part, due to the bacterium’s ability to sense changes in
environmental signals and rapidly alter its gene expression profile in response to these changes
(15-21). Several studies have demonstrated the ability of S. pyogenes to integrate various
environmental cues as a mechanism for global gene expression changes. These signals include
temperature, osmolarity, pH, and nutrient availability (17, 22-24).
Lacking functional alternative sigma factors, S. pyogenes transcription is under the control of
a number of two component systems and stand-alone response regulators to control gene
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expression in response to various signals (17, 22, 25-31). Several of these regulators are known
to control gene expression in response to specific nutritional cues. RelA, CodY, and RopB are all
global transcription regulators whose function is linked to amino acid catabolism (29, 30, 32-34).
However, in addition to regulating a number of metabolic genes, all three regulators control a
number of virulence factors (29, 30, 32, 33). LacD.1, which was first identified as a regulator of
the cysteine protease SpeB, functions in response to the levels of the glycolytic intermediates
glucose-6-phosphate and dihydroxyacetone phosphate, indicating that it too functions as a
regulator of carbon catabolic control (35, 36). Additionally, it’s been shown that glucose
concentrations can have a global effect on gene expression in S. pyogenes, affecting both
alternative catabolic operons and numerous virulence factors, and this response largely
controlled through CcpA (5, 7, 8, 37). Taken together, this data indicates that nutrient
availability and virulence factor production are intimately linked through the actions of multiple
global regulatory pathways.
Numerous studies have been undertaken to assess the global effects of CcpA regulation and
its contributions to pathogenesis (2, 5-8). From these studies, several important pieces of
information have been derived. First, microarray analysis has shown that, although a significant
number of CcpA-regulated genes are also glucose-regulated genes, there is also a subset of genes
regulated by CcpA only, demonstrating that CcpA function is controlled by glucose-dependent
and -independent signals (5). Second, although CcpA primarily acts as a transcriptional
repressor, expression of a small subset of genes, including the major virulence factor SpeB, is
positively regulated by CcpA (2, 5). Finally, loss of the ccpA gene results in an attenuated
virulence phenotype in a murine model of soft tissue infection (2, 5). Transcriptional analysis of
CcpA-regulated genes during the course of a 7-day infection with either WT or the CcpA- mutant
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showed temporal misregulation of targets in the mutant strain including both metabolic and
virulence genes. In particular, patterns of misregulation were most strongly associated with
earlier time points, suggesting that CcpA regulation is crucial during the early stages of
colonization (5). Additionally, the CcpA- mutant has also been shown to be defective in
asymptomatic mucosal carriage using a murine vaginal colonization model, and this defect was
primarily attributed to the dysregulation of the lactate oxidase gene lctO (13). Taken together,
these data demonstrate the significant and complex role that CcpA regulation has in controlling
the outcome of infection in multiple tissue environments.
A caveat to these data, however, is that these studies were limited to utilization of a ccpA
null mutant for analyses, which provides information exclusively on the effects of the loss of
CcpA function. Therefore, to further analyze the effect of CcpA activation and its role in
pathogenesis, we designed and tested a constitutively active mutant allele of CcpA, CcpAT307Y.
The constitutively repressive activity of the CcpAT307Y mutant was verified by analyzing
transcript levels of a series of known CcpA targets in vitro. The CcpAT307Y over-activation
mutant was then tested in vivo using two different mouse models of disease, subcutaneous soft
tissue infection and vaginal mucosal colonization and compared to WT and CcpA-. The results
indicate that over-activation of CcpA causes attenuation of virulence in soft tissue, but allows for
extended carriage during asymptomatic mucosal colonization.
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RESULTS
Construction of CcpA “super repressor”. In WT S. pyogenes CcpA functions as a repressor
of gene expression in the presence of high glucose concentrations (Fig. 1). When glucose is
abundant, it is rapidly taken up into the cell and metabolized through the glycolytic pathway
(38). During this process there is a high intracellular concentration of the glycolytic intermediate
fructose-bis-phosphate (FBP). FBP levels in the cell influence the enzymatic activity of the
protein HprK, which can act as both a kinase and a phosphatase to control the phosphorylation
state of the phosphocarrier protein HPr (38, 39). At high FBP levels, HprK functions as a kinase
to phosphorylate HPr at the serine 46 residue (38, 39). This serine-phosphorylated form (P~SerHPr) then functions as a cofactor for CcpA activation. The binding of two molecules of P~SerHPr to the CcpA dimer induce a conformational change, shifting the two CcpA molecules from

Figure	
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  catabolite	
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  metabolized,	
  
resulting	
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  the	
  glycolytic	
  intermediate	
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  stimulates	
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  with	
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  promoters	
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  sites.	
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an open and inactive conformation to a closed conformation, which can then bind to DNA at
specific promoter sites (Fig. 1, 2A) (40).
We sought to create a constitutively active form of CcpA through the mutation of a single
amino acid, Thr 307. Previously, the crystal structure of CcpA from the Gram-positive bacterium
Bacillus megaterium was solved (40). That work identified a series of amino acids found at the

Figure	
  2.	
  Design	
  of	
  constitutively	
  active	
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  (A)	
  WT	
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  remains	
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  an	
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  and	
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  with	
  CcpA	
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  the	
  regulator	
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  can	
  
then	
  bind	
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  mimicking	
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  binding.	
  CcpAT307Y	
  
functions	
  independently	
  from	
  glucose	
  concentrations	
  and	
  is	
  active	
  under	
  all	
  conditions.	
  

dimer interface that were involved in the structural rearrangement of the CcpA dimer upon
P~Ser-HPr binding. In particular, they found that replacing the Thr with an amino acid with a
bulky side group would mimic P~Ser-HPr binding and force the CcpA dimer into its active,
closed conformation absent any cofactor binding (40). In S. pyogenes this key residue is Thr307.
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Therefore, through directed mutagenesis the threonine residue was replaced with a tyrosine to
create the mutant CcpAT307Y (Fig. 2B).

CcpAT307Y is constitutively active in the absence of glucose signal. To test for growth defects
of the CcpA- and CcpAT307Y, both strains plus WT were cultured overnight in both a glucose rich
media (THY) (Fig. 3A) and a low carbohydrate media (C medium) (Fig. 3B). Growth in THY
medium was identical to WT for both CcpAand CcpAT307Y, indicating that in glucose
rich conditions these mutants have no
growth defects. When comparing growth in
C medium, both WT and CcpA- mutant
strains grew at a similar rate and reached a
final OD600 of 0.40, however the CcpAT307Y
mutant had a slight growth defect and
reached a final OD600 of 0.35.
To test for the functionality of the
CcpAT307Y mutant, real time RT-PCR was
performed on a series of known CcpA
Figure	
  3.	
  Growth	
  of	
  CcpA	
  mutants	
  in	
  vitro.	
  Growth	
  
of	
  WT	
  and	
  CcpA	
  mutants	
  were	
  grown	
  in	
  (A)	
  rich	
  
media	
  (THY)	
  or	
  (B)	
  minimal	
  medium	
  (C	
  medium).	
  

target genes (2, 5). Previously published
work identified the lactate oxidase gene

lctO as being repressed by CcpA in response to glucose (5). For this analysis WT, CcpA-, and
CcpAT307Y strains were grown in unmodified C medium or C medium supplemented with 0.2%
glucose. Transcript levels were measured from cells grown to exponential phase and normalized
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to WT in unmodified C medium (Fig. 4A). The addition of glucose resulted in a 10-fold
reduction in transcript abundance in WT cells, yet had no effect in a CcpA- strain, indicating that
glucose-dependent CcpA-activation is responsible for lctO repression.
Furthermore, the CcpAT307Y strain,
displayed constitutively low lctO transcript
abundance compared to WT regardless of
glucose content, demonstrating that this
CcpAT307Y mutant is able to repress genes in
the absence of a glucose signal.
Although CcpA primarily acts as a
repressor of gene expression, in some cases
it can enhance transcription (2, 5). One gene
that is positively regulated by CcpA is speB,
the gene that encodes the SpeB cysteine
protease (2). WT and the two CcpA strains
were grown in C medium and transcript
Figure	
  4.	
  CcpAT307Y	
  is	
  constitutively	
  active	
  in	
  the	
  
absence	
  of	
  glucose	
  signal.	
  WT,	
  CcpA-‐,	
  and	
  
CcpAT307Y	
  strains	
  w ere	
  grown	
  in	
  C	
  medium	
  with	
  or	
  
without	
  glucose	
  to	
  exponential	
  phase	
  (OD600	
  of	
  
0.2).	
  Total	
  RNA	
  w as	
  isolated	
  and	
  used	
  for	
  real-‐time	
  
RT-‐PCR	
  analysis	
  of	
  lctO	
  (A)	
  or	
  speB	
  (B)	
  transcript.	
  	
  

levels were measured from cells at
stationary phase, when speB is maximally
expressed (Fig. 4B). As previously

published, the CcpA- strain displayed reduced transcript levels compared to WT. Interestingly,
the CcpAT307Y mutant displayed an approximately 50-fold increase in speB transcript compared to
WT. Taken together, these data indicate that the CcpAT307Y mutant is constitutively active, and
depending on the target gene, it induces either hyper-repression or hyper-activation.
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CcpAT307Y is attenuated in a murine soft tissue infection. Loss of CcpA is associated with
attenuation in a murine soft tissue infection model (5). Therefore, we sought to investigate the
effects of constitutive CcpA repression on virulence in this mouse model. For this analysis mice
were infected with WT, CcpA-, or CcpAT307Y and lesion areas were compared at day 3-post
infection (Fig. 5A and B). Comparison of lesion sizes shows that infections with either CcpA
mutants formed significantly smaller lesions than a WT infection. Additionally, lesions were
dissected at day 3 and tissue was plated to count bacterial CFU (Fig. 5C). Although the CcpAmutant had significantly reduced CFU, the CcpAT307Y mutant, however, had similar CFU to WT
at day 3 despite the strong attenuation phenotype seen with the lesion data. Taken together, this
data shows that although both the CcpA- mutant and the CcpAT307Y mutant are attenuated in
lesion formation, however, only the CcpA- strain has reduced CFU, suggesting that the cause of
the attenuation of these two strains is unique for each strain.
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Figure	
  5.	
  CcpA	
  mutants	
  have	
  reduced	
  virulence	
  in	
  soft	
  tissue	
  infections.	
  
Hairless	
  SKH1	
  mice	
  w ere	
  infected	
  subcutaneously	
  with	
  W T,	
  CcpA-‐,	
  or	
  
CcpAT307Y	
  and	
  the	
  resulting	
  lesions	
  formed	
  (A)	
  and	
  CFU	
  (B)	
  were	
  measured	
  
at	
  day	
  3	
  post-‐infection.	
  Data	
  shown	
  are	
  pooled	
  from	
  2	
  independent	
  
experiments.	
  Differences	
  between	
  groups	
  were	
  tested	
  for	
  significance	
  using	
  
the	
  Mann-‐Whitney	
  U	
  test	
  (**	
  P	
  <	
  0.01,	
  ***	
  P	
  <	
  0.001).	
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CcpA mutants have differential phenotypes in murine mucosal colonization model. In
addition to causing inflammatory infections of the skin, S. pyogenes can asymptomatically
colonize mucosal tissue (13). Recently, a model of asymptomatic carriage in the murine vaginal
mucosa was developed and it was shown that a CcpA- mutant was attenuated in this system (13).

Figure	
  6.	
  CcpA	
  mutants	
  have	
  differential	
  phenotypes	
  in	
  mucosal	
  colonization	
  model.	
  
Estrogenized	
  C57BL/6J	
  mice	
  were	
  vaginally	
  inoculated	
  at	
  day	
  0	
  with	
  1x106	
  CFU	
  of	
  
streptomycin-‐resistant	
  WT,	
  CcpA-‐,	
  or	
  CcpAT307Y	
  mutants.	
  Vaginal	
  washes	
  were	
  collected	
  at	
  
the	
  time	
  points	
  indicated	
  and	
  processed	
  for	
  determination	
  o f	
  CFU.	
  Each	
  symbol	
  represents	
  
the	
  mean	
  and	
  standard	
  error	
  of	
  the	
  mean	
  d erived	
  from	
  at	
  least	
  5	
  mice	
  per	
  group.	
  A	
  
repeated	
  measure	
  analysis	
  was	
  used	
  to	
  compare	
  mutants	
  to	
  WT.	
  

This finding demonstrated that CcpA regulation was essential for long-term mucosal
colonization of S. pyogenes. Given this information, the next question to address is what effects a
CcpAT307Y mutant will have on mucosal colonization. WT, CcpA-, or CcpAT307Y strains were
vaginally inoculated into pre-estrogenized C57BL/6J mice and colonization was monitored by
counting viable CFU from vaginal washes collected over the course of 60 days. WT S. pyogenes
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maintained a high level of colonization through day 22, after which there was a rapid drop in
CFU (Fig. 6). The CcpA- mutant displayed an immediate drop in CFU, leading to complete
clearance by day 12 (Fig. 6). Conversely, the CcpAT307Y mutant had a distinct phenotype than
either WT or CcpA-. CFU from the CcpAT307Y mutant dropped several logs over the first 14 days,
but maintained higher numbers than the CcpA- mutant. Interestingly, the CcpAT307Y mutant
displayed extended carriage, with approximately 105 CFU detected at day 60 post inoculation,
long after WT was cleared (Fig. 6). This data indicates that enhanced CcpA activity is beneficial
to the bacteria during mucosal colonization.
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DISCUSSION
For a pathogenic bacterial species such as Streptococcus pyogenes, precise spatial and
temporal expression of virulence factors is essential for the pathogen to achieve maximum
fitness in host tissue. Disruption of various regulatory pathways, leading to misregulation of
numerous target genes, has been shown to be detrimental for the bacterium (2, 13, 18, 41, 42). In
S. pyogenes, the catabolite repressor protein CcpA has been established as an important growth
phase-dependent regulator that is responsible for controlling a large number of metabolic and
virulence genes (2, 5). Although multiple studies have explored the role of CcpA through loss of
function mutants, this study sought to characterize the effects of CcpA activation on
pathogenesis.
In this study we have developed a constitutively active form of CcpA to use as a tool to
explore the role of catabolite repression on virulence in multiple tissue environments. In vitro
transcription levels of two known CcpA target genes demonstrated that the mutant, CcpAT307Y, is
a functional protein, capable of either constitutive repression or constitutive activation of gene
expression, depending on the target gene. In vivo experiments demonstrate that misregulation of
the CcpA regulon, in either a CcpA- or CcpAT307Y mutant, alters the outcome of both the soft
tissue infection and mucosal carriage. In the case of the inflammatory soft tissue model, both
CcpA mutants displayed reduced virulence, but only CcpA- was impaired in growth. In the
vaginal mucosal, CcpA- displayed reduced carriage compared to WT. Conversely, the CcpAT307Y
mutant had an extended carriage phenotype, indicating that excessive catabolite repression may
be beneficial for the bacterium in this environment.
The finding that both CcpA mutants are strongly attenuated in a soft tissue infection
demonstrates the importance of proper temporal control of gene expression to maximize fitness
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of the bacteria. CcpA-mediated regulation is a dynamic process, linking gene expression to the
constant changes in nutrient availability. Loss of this regulatory system, either through loss of or
hyper-activation of CcpA, appears to be equally detrimental to pathogenesis of S. pyogenes.
However, the specific causes of this attenuation appear to be distinct for each of the CcpA
mutants.
The CcpA- infection lead to reduced lesion areas and fewer recoverable CFUs from lesion
tissue compared to WT. This finding indicates that the CcpA- mutant displayed a growth defect
in vivo that was not observed in vitro, and this defect most likely contributed to the attenuation
phenotype. One possible cause of this defect is that a CcpA- infection induces an altered host
response, leading to more efficient clearance of the bacteria. Preliminary investigations into host
immune response during infection have found that the loss of CcpA resulted in a significant
alteration in cytokine response during infection (C. Kietzman and M. Caparon, unpublished). In
particular, TNFα was significantly upregulated in a CcpA- infection compared to WT (C.
Kietzman and M. Caparon, unpublished). This finding suggests that a CcpA- mutant may be
deficient in producing an as-yet-unknown immune modulating virulence factor, resulting in a
robust TNFα response and more efficient bacterial clearance.
Conversely, an infection with CcpAT307Y created smaller lesions than WT, but had
equivalent amounts of recoverable bacteria from lesion tissue as WT. In this case, the observed
attenuation may be due to repression of one or more virulence factors necessary for the tissue
damage and necrosis that occurs when skin lesions develop. One possible candidate responsible
for this is the cytolysin Streptolysin S (SLS), which is both repressed by CcpA and is associated
with tissue damage and lesion formation (43-47). In a CcpAT307Y infection SLS would
theoretically be constitutively repressed, and without this key virulence factor, less tissue damage
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would likely occur. It also remains possible that the attenuation of the CcpAT307Y mutant is the
result of excessive repression of multiple virulence factors, including SLS.
Similar to skin infections, the two CcpA mutants displayed distinct phenotypes when
infecting the murine vaginal mucosa. The CcpA- mutant’s rapid depletion and clearance is
similar to what has been seen previously for this mutant in mucosal tissue (13). In that work the
authors demonstrate that the lack of successful colonization is due to over-production of LctO,
leading to toxic levels of hydrogen peroxide production (13). The CcpAT307Y mutant, however,
displayed an initial loss of CFU early in colonization, but had an extended carriage greater than
both the CcpA- strain and WT. This pattern suggests that CcpA-mediated repression may be
detrimental during early stages of mucosal colonization, but beneficial for long-term
colonization. It has been suggested that the bacterial cells could be in a metabolically inactive
state during long-term carriage (13) and, if this were the case, repression of transcription for a
large set of genes would allow the cell to conserve energy and possibly persist longer in the
tissue.
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MATERIALS AND METHODS
Bacterial strains and growth conditions. Standard molecular cloning techniques utilized the
Escherichia coli strain TOP10 (Invitrogen). Cultures were grown in Luria-Bertani medium at
37°C. Streptococcus pyogenes strain HSC5 (48) and mutant derivatives were utilized in this
study. Strains were grown in Todd Hewitt broth (THYB) with 0.2% yeast extract (Difco) or C
medium, adjusted to pH 7.5 as described previously (49). Routine growth conditions utilized
sealed culture tubes incubated at 37°C under static conditions. Streptococcal strains grown on
solid medium containing 1.4% Bacto agar (Difco) were cultured in a sealed jar with a
commercial gas generator (GasPak catalogue no. 70304, BBL). For experiments utilizing glucose
supplementation, filter sterilized 20% (w/v) stock solution was used to add glucose (Sigma) to a
final concentration of 0.2% to the media. All media used were sterilized in an autoclave prior to
supplementation. When appropriate, antibiotics were added at the following concentrations:
erythromycin 1 mg/mL.
Construction of mutants. All references to genomic loci are based on the genome of HSC5
(48). The mutant strain CcpA- was described previously (2). The modified allele for CcpA
(L897_02310), CcpAT307Y, was generated using the Quikchange XL II mutagenesis kit (Agilent
Technologies) and the PCR primers CcpA T307Y F (5’GTGCTGTTAGCATGCGGATGTTGTATAAAATCATGAACAAAAGAAGAGT) and CcpA
T307Y R (5’-ACTCTTCTTTGTTCATGATTTTATACAACATCCGCATGCT- AACAGCAC)
to create plasmid pEP44. The modified allele was transferred to the HSC5 chromosome using the
allelic replacement vector pGCP213 (50) as described (51). All molecular constructs and
chromosomal structures of all mutants were verified using PCR and DNA sequencing (Genewiz,
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South Plainfield, NJ) using oligonucleotide primers (IDT, Coralville, IA) of the appropriate
sequences.

Isolation of RNA and transcript analysis. Transcript abundance of selected genes was
analyzed as previously described (52). Briefly, overnight cultures were diluted 1:25 into fresh C
medium with the appropriate supplement added (see text) and harvested at mid-log phase (OD600
0.2). Total RNA was isolated using Qiagen RNeasy Mini kit per the manufacturer’s protocol.
RNA was subjected to reverse-transcription (RT) using iScript (Bio-Rad) per manufacturer’s
protocol. RT-PCR analysis of cDNA samples were performed using iQ SYBR Green Supermix
(Bio-Rad). RT-PCR primers for lctO and speB reported previously (2). Relative transcript
abundance was determined using the ΔΔCt method using recA transcript as a standard and are
presented in comparison to wild type. The data shown are the means and the standard deviation
from triplicate determinations of at least two separate biological samples prepared from at least
two independent experiments.
Infection of mice. Infection of murine subcutaneous tissue was conducted as described
previously (53, 54). Briefly, 5-to-6-week-old female SKH1 hairless mice (Charles River Labs)
were injected subcutaneously with approximately 107 CFU of S. pyogenes of the strains indicated
in the text. Following infection, the resulting ulcers formed were monitored over a period of
several days by digital photography and lesion areas measured as previously described (53). Data
presented is pooled from at least two independent experiments with at least 10 mice per
experimental group. The ability of strains to maintain asymptomatic colonization of the murine
vaginal mucosa was measured in C57BL/6 mice, as previously described (13). Colonization was
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assessed at selected time points over the course of 60 days by monitoring recoverable CFUs in a
50μL vaginal wash. Data presented was collected from a single infection of 3-5 mice per strain.
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Chapter V
Conclusions

	
  
	
  

146	
  

CONCLUSIONS
Streptococcus pyogenes is an extremely versatile bacterium, as it can colonize numerous
different tissue types within the human host as well as induce an inflammatory or
noninflammatory infection (1-3). A key factor for this versatility lies in the bacterium’s ability to
monitor various environmental signals in the surrounding tissues and rapidly alter its global
transcriptome to adapt itself for survival in a particular niche (4-8).
Through comparisons of gene expression patterns observed in infected tissue to
expression patterns from various in vitro growth conditions, it was previously determined that
the infected tissue environment is low in glucose and is low in pH (10). Additionally, these two
metabolic cues are linked due to the simple fermentative metabolism present in S. pyogenes (1114). Glucose fermentation results in the production of a large amount of organic acid end
products, which accumulate in the local environment and cause a significant drop in pH of the
surrounding tissue (11-13). Additionally, both pH and glucose levels have been shown to be
signals utilized by the bacterium to induce global transcriptional changes (10, 15), however the
specific mechanism by which these signals are sensed by the various regulatory pathways
remains largely unclear. The aim of this work was to identify these regulatory pathways and
elucidate their role in S. pyogenes pathogenesis. The major findings of this work include: 1) S.
pyogenes is able to utilize malate as an alternative carbon source through the malic enzyme
pathway, 2) regulation of the ME pathway in S. pyogenes is distinct from other LAB in that it is
positively regulated by low pH and is controlled by a CcpA-independent form of catabolite
repression, 3) loss of any ME genes can alter the outcome of an infection, 4) temporal expression
of the virulence factors SPN and SLO is controlled by environmental pH, 5) pH regulation of spn
and slo require the two-component system CovRS and the protein RocA, 6) RocA is not a
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histidine kinase as previously reported in the literature, but is involved in a transcriptional
regulatory pathway that includes CovR and CovS, and 7) constitutive activation of CcpA alters
the outcome of disease in two different mouse models, leading to a unique phenotype distinct
from either a WT or CcpA- infection.
These studies provide new insights into the relationship between metabolism and pathogenesis in
S. pyogenes. In particular, it explores the effects of carbon source utilization on local tissue
remodeling and the regulatory mechanisms that the bacterium uses to adapt to these specific
changes.
During the initial stages of a soft tissue infection, glucose levels are at their highest. The
available glucose will be rapidly taken into the bacterial cell and metabolized, leading to
repression of alternative catabolic operons through both CcpA-dependent and –independent
pathways. Also during the early stages of infection the bacterial cells will begin to produce and
secrete toxins SPN and SLO, among others, to induce local tissue damage and cytotoxicity. Over
time, as glucose continues to be metabolized, both the concentration of glucose as well as the pH
begins to decrease. In response to these signals, alternative catabolic genes, such as the malic
enzyme genes, are expressed, as the cell needs to scavenge for alternative carbon sources. At this
point, malate is abundant at the site of infection, likely being released from host cells due to the
expression of several cytotoxic proteins, including SPN and SLO. While the acidic pH induces
expression of the ME genes, it simultaneously acts as a signal to turn off expression of spn and
slo, and this regulation is carried out via RocA and CovRS. Finally, upon depletion of glucose,
CcpA repression is relieved, allowing for expression of genes necessary for late stages of
colonization and dissemination.
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FUTURE DIRECTIONS
Determine the regulatory pathway involved in activation of malic enzyme expression
The work presented here has established that the malic enzyme genes are under a form of
catabolite repression known as induction prevention, and this process is mediated through a
phosphorelay system that includes the general PTS proteins EI (encoded by the gene ptsI) and
HPr. What is currently unknown is the intermediate step between formation of P~His-HPr and
expression of the maeKR and maePE operons. Determination of the missing link in this
regulatory pathway will provide new insights into alternative carbon catabolite repression
pathways beyond the heavily studied CcpA side of catabolite repression.
One possible scenario is that the phosphate from P~His-HPr would be transferred to
another, currently unknown, transcriptional regulator, which then leads to activation of
transcription of the MaeKR regulatory operon. It has been shown in S. pyogenes and a number of
other bacteria that the phosphate from P~His-HPr can be directly transferred to regulatory
proteins containing a conserved PRD domain (16, 17).
In S. pyogenes there are three transcriptional regulators predicted to contain PRD
domains: Mga, RofA, and an uncharacterized RofA-like protein (RALP). Preliminary data
indicates that neither Mga nor RofA are required for ME expression or malate utilization (data
not shown). Work is currently in progress to investigate the third RALP protein as the possible
intermediate regulator in this regulatory pathway.
An alternative possibility is that a different, non-PRD regulator, or a PRD regulator not
identified via genome annotation or BLAST searches is involved in malate catabolism. We
currently plan to employ a transposon screen to unbiasedly identify mutants that are unable to
utilize malate. We predict to find known genes including all four malate utilization genes (maeE,
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maeP, maeK and maeR), as well as HPr and PtsI, and any novel genes, including possible
transcriptional regulators. A more direct way to identify this potential regulator would be to
perform a pull-down experiment using the mae promoter region to see what binds to the DNA
sequence, followed by mass spectrometry analysis to identify these proteins.
A final possible hypothesis is that the transcriptional regulator in question is MaeK itself.
I find this unlikely due to the lack of a PRD domain. However, this is still a possibility that
should be tested. The most direct way to do his would by an in vitro kinase assay to look for the
direct transfer of the phosphate from P~His-HPr to MaeK.

Determination of RocA’s functional activity
There has been limited work done on RocA and its role in transcriptional regulation and
virulence. The work presented here refutes the previously published data suggesting that RocA is
a functional histidine kinase, but supports the findings that RocA interacts with the CovRS TCS.
The next step in understanding this regulatory circuit would be to determine what, if any,
enzymatic activity the RocA protein has. Structural prediction software (18) categorizes RocA as
a histidine kinase, based in part on the presence of a putative ATPase domain, among other
features. Data presented here has established that this protein is not functioning as a histidine
kinase, as mutating all histidine residues within the predicted cytoplasmic domain does not affect
RocA’s regulatory activity on SPN and SLO expression. It is also unlikely that the predicted
ATPase domain is functional, as several key residues necessary for its enzymatic activity are
absent in the sequence of RocA. However, these findings have not yet been verified
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biochemically. What is clear is that RocA is a necessary part of the regulatory system controlling
the spn operon in response to pH.

Figure	
  1.	
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  of	
  action	
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  pseudokinases.	
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  identified	
  pseudokinases	
  
have	
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  associated	
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  the	
  four	
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  integration.	
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The next step in this process will be to determine how RocA, CovR, and CovS work
together to coordinate the regulation of this virulence operon. One possibility that I find most
intriguing is that RocA functions as a pseudokinase, a protein that structurally resembles a kinase
but is lacking any enzymatic activity. Pseudokinases are present in all domains of life (9, 19-24)
and all known pseudokinases function in at least one of four mechanisms to modulate cellular
activity (see Fig. 1). Perhaps the most likely mechanism for RocA’s function is modulation of
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the phosphorylation of CovR (Modulator). It’s been shown in previously published work that
CovR’s activity is dependent on its phosphorylation state, where different subsets of genes are
repressed by CovR depending on its phosphorylation state (6, 25). Additionally, CovS is known
to maintain both kinase and phosphatase activity (6, 25). Therefore, the next step in this work
should be to analyze the phosphorylation state of CovR in the presence or absence of RocA.
Finally, it is highly probable that RocA controls the expression of numerous genes in S.
pyogenes. Recent work on RocA function suggests that this protein may also function as a
regulator of a subset of genes independent from the CovRS regulon (26). Additionally, many of
the genes that were identified as being part of the RocA regulon are metabolic genes (26),
suggesting that RocA may be an as-yet unidentified metabolic regulator. To verify this and to
characterize the complete RocA regulon, a microarray or RNA-Seq experiment would provide an
in depth analysis of RocA’s contribution to
transcriptional regulation and virulence. Of particular interest would be to test a WT and RocA
mutant grown in buffered media, either neutral or acidic. If, in fact, RocA is a key regulator for
acid stress response there is likely many more genes being regulated by this protein. I think this
is just the beginning of the RocA story and it has the potential to provide some really interesting
and novel findings, particularly in relation to CovRS.

Analyzing the effect of CcpA activation on fitness and pathogenesis
One avenue to explore with the CcpA mutants is to study the effects of CcpA-mediated
regulation on growth and metabolic fitness. CcpA is a global regulatory protein and is the
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primary regulator for most of the proteins in the main glycolytic pathway (15) and yet growth of
either of the CcpA mutants was unaffected in vitro under the conditions tested. An interesting
follow-up to those initial experiments would be to test WT and CcpA mutants in a range of
conditions and with several different carbohydrate substrates. Multiple aspects of cell growth
could be measured under these conditions such as final yield, growth rate, metabolic
intermediates, and fermentation end products. Evaluating these different measurements could
provide insights into CcpA regulation and how this control is affecting the overall fitness of the
bacteria.
When considering the effects of CcpA regulation on virulence, the data presented in this
work establishes that both the CcpA- and CcpAT307Y mutants were severely attenuated in a mouse
model of soft tissue infection. It’s been shown previously that CcpA regulates a number of
known virulence factors, some of which have immune modulatory function (15, 27). S. pyogenes
has been shown to induce a number of inflammatory cytokines within the host during an
infection, and work from the Caparon lab has shown that the loss of CcpA results in a significant
alteration in cytokine response during infection. In particular, TNFα was shown to play an
important role in controlling virulence in a CcpA- infection (C. Kietzman and M. Caparon,
unpublished). The previous studies indicate that the loss of CcpA repression has a measurable
effect on transcriptional regulation and host immune response throughout the course of an
infection. An important next step in understanding CcpA and its role in pathogenesis will
therefore be to measure host immune factors during a soft tissue infection with the superrepressor CcpAT307Y. In particular, we will look for alterations in inflammatory cytokines by
ELISA or real time RT-PCR, as a more robust immune response may be responsible for the
attenuation in the CcpAT307Y mutant.
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